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ABSTRACT 
Effectiveness of services for Prevention of Mother to Child Transmission (PMTCT) of Human 
Immunodeficiency Virus (HIV) depends on viable and efficient health systems, adherence to and 
utilization of services. Despite strategies to provide access to PMTCT of HIV services, utilization 
of these services remain low in Nigeria thereby increasing child morbidity and mortality from 
HIV-related causes. Adherence to comprehensive HIV/AIDS care, for both the mother and baby, 
remain a challenge for HIV positive women. Utilizing the Health Belief Model and Social Support 
Theory, this qualitative study explores factors influencing utilization and adherence to PMTCT 
services by mothers living with HIV/AIDS in Rivers State, Nigeria. Purposive sampling 
procedures were used to select 40 study participants including 20 HIV positive mothers and 20 
health care workers as key informants. Findings indicate that high self-perceived susceptibility to 
HIV influences utilization and adherence to PMTCT services among mothers living with HIV and 
AIDS in Rivers State. Although utilization and adherence to PMTCT were reported very high 
among this population, there were however challenges and barriers to optimal utilization of 
PMTCT. These include unavailability of test kits, antiretroviral medication stock-outs, and 
inadequate human resources for health. High transport, PMTCT and antenatal care costs were 
identified as the major socio-economic barriers to PMTCT administration as well as the high 
financial burden of formula feeding for women that preferred exclusive formula feeding. In 
addition to increased numbers of health care workers trained in PMTCT service delivery, 
recommendations for a public health approach to service delivery and a streamlined primary care 
strategy are proposed. These include social and community activities to address HIV/AIDS stigma, 
improving awareness of PMTCT facts, addressing gender relations and encouraging male 
participation. Inter-ministerial collaborations and targeted partnerships are also recommended for 
expanding coverage and ensuring optimal utilization of PMTCT services. 
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CHAPTER 1 
INTRODUCTION 
This chapter presents the background and context to the study including the global HIV prevalence 
with specific reference to the prevalence among women and children in Nigeria. This is followed 
by an outline of the National PMTCT guidelines in Nigeria as well as a statement of the research 
problem. Thereafter, the research aims, objectives and questions are highlighted. The chapter 
finally discussed reasons why a research of this nature is relevant and clarifies some key concepts. 
 
1.1 Background and Context 
Health development in most of the low- and middle-income countries has been traditionally seen 
as provision of health care service that is affordable, accessible and of good quality thus improving 
the health status for the majority of the people (Alubo, 2001; World Health Organization (WHO), 
2000). Better health for all has been described as the most important purpose for the existence of 
a health system. This means that the health system must serve the goals of ensuring better health, 
responsiveness to the health needs of the people, and achieving fair financing through reduced 
financial risk to households (WHO, 2000). Health systems are in principle complicated, and varied 
in practice (Musgrove, 1996).  
The spread of the Human Immunodeficiency Virus (HIV) pandemic has been shown to 
compound the pressure on national health systems by greatly increasing the demand for health 
services by HIV-infected persons (John-Langba, 2013). HIV has been a threat to social and 
economic progress of most affected countries and has come to be one of the most serious health 
and development challenges in the world. As a result of the prevalence of HIV and Acquired 
Immune Deficiency Syndrome (AIDS) epidemic, modest gains made in maternal and child 
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survival during previous decades are now adversely being affected (WHO, 2007). In 2017, about 
36.9 million people were living with HIV and 1.8 million new infections were recorded worldwide 
according to the United Nations Program on AIDS (UNAIDS, 2018). About 940,000 pregnant 
women were living with HIV in 2017 while there were 180,000 children aged between zero and 
fourteen years who were newly infected in the same year (UNAIDS, 2018). HIV/AIDS is also one 
of the major causes of disease burden in Sub-Saharan Africa (Dwyer-Lindgren et al., 2017). 
According to UNAIDS (2018), the region that carries the highest burden of HIV is Sub-Saharan 
Africa with an estimated 980,000 new HIV infections among adults in 2017. Also, 59 per cent of 
these new HIV infections in Sub-Saharan Africa in 2017 were women (UNAIDS, 2018).  
Nigeria, Africa’s most populous country has an estimated 1,900,000 million PLHIV 
making it the country with the world’s highest burden of HIV after South Africa and has a National 
prevalence rate of 1.4 per cent according to the National Agency for the Control of AIDS (NACA, 
2018). According to NACA (2018), females have a significantly higher prevalence rate of 1.9 per 
cent than men with an estimated 0.9 per cent. The number of new HIV infections was 210,000 in 
2017 of which 36,000 were among children. Nigeria comprises 36 states divided into 6 geopolitical 
zones which have varied HIV prevalence rates as depicted in figure 1.  
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Figure 1: Distribution of HIV Prevalence by States and Geographic Region 
 
Source: National Agency for the Control of AIDS (NACA, 2018) 
The map in figure 1 shows the states with the highest HIV prevalence rates or states with 
prevalence rates greater than 2 per cent. Based on figure 1, HIV prevalence rates were highest in 
7 states namely: Akwa Ibom (5.6%), Benue (4.9%), Rivers (3.8%), Taraba (2.7.5%), Anambra 
(2.4%), Enugu (2.1%) and Abia (2.1%). There is no regional pattern in these prevalence rates 
because Akwa Ibom, a state in the South-South region of Nigeria had the highest HIV prevalence 
rate according to the NACA (2018) followed by Benue State which is in the North Central region. 
However, NACA (2018) reveals that three states in the South East region are among the 7 states 
with the highest prevalence rates greater than 2%, while two states were from the South South 
region with no state from the North West region. These regional divisions reflect varying ecologies 
and climates, along with differing population characteristics and therefore varied realities of 
distinct regions, ethnic and religious groups, and a myriad of other factors (Agunwambaet al., 
2009). 
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Heterosexual sexual intercourse which is the leading route of transmission of HIV accounts 
for about 42 per cent of HIV infections and Mother to Child Transmission (MTCT) accounts for 
90 per cent of HIV infections in children (NACA, 2018). With an MTCT rate of 22 per cent in 
Nigeria, the 2016 National HIV Strategy for Adolescents and Young People 2016-2020 in Nigeria 
states that MTCT accounts for a fairly high proportion of infections among adolescents aged 
between 10 and 18 years old (UNAIDS, 2018). Recognizing that based on a UNAIDS (2010) 
report, an estimated 20% of all global HIV infections and more than 95% of pediatrics HIV 
transmissions occur as a result of MTCT, the World Health Organization (WHO) developed a 
comprehensive approach for Prevention of Mother to Child Transmission (PMTCT) of HIV. This 
is among various tools available to countries for preventing HIV transmission such as condom use, 
socio-behavioral interventions, blood screening and male circumcision. The WHO guidelines for 
PMTCT intervention comprise the following services:  
i. Antenatal services and HIV testing during pregnancy,  
ii. Use of antiretroviral treatment (ARV) by pregnant women living with HIV,  
iii. Safe childbirth practices  
iv. Appropriate infant feeding,  
v. Infant HIV testing and  
vi. Other post-natal healthcare services. 
Since 2008, the policy and guidelines for PMTCT in Nigeria recommended that pregnant 
women should be enrolled in early antenatal care where they are offered routine HIV Counseling 
and Testing (HCT) at the point of registration in antenatal care clinics (Adejumo, Erhunwuse & 
Oyetunde, 2013). After consenting to PMTCT regimen, women with positive HIV test results are 
counseled and thereafter enrolled in and offered services like ARV therapy and options for safer 
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delivery and infant feeding (Adejumo et al., 2013).  The mother-infant pairs are then followed 
from the time of delivery until the baby has reached 18 months postpartum postpartum (Adejumo 
et al., 2013).  With these activities forming the heart of the program, PMTCT was developed in 
Nigeria and laid down in the National Scale-up Plan towards Elimination of MTCT of HIV, 
National Policy for HIV/AIDS and the National HIV/AIDS Strategic Plan 2010-2015. 
In 2002, Nigeria initiated the PMTCT program in one hospital in each geo-political zone 
and as at 2012, there were 1352 health facilities offering PMTCT services across the country 
(NACA, 2013). Table 1 shows some of the guidelines for PMTCT service provision in Nigeria:  
Table 1: Guidelines for Comprehensive PMTCT Services in Nigeria 
Specific PMTCT Intervention Guideline 
HIV testing and counseling All antenatal care facilities shall offer HIV testing and 
counselling for all pregnant women as part of existing 
integrated reproductive health care services and shall 
include referrals for family planning counselling and 
other services when necessary. Testing will be 
offered routinely with the right to opt-out. 
Components of HIV testing include:  
i. Pre-test information 
ii. HIV testing and same day result 
iii. Post-test counselling 
iv. Follow-up counselling. 
When in labour: 
i. Determine HIV test history 
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ii. Discuss the benefits of testing and ARV 
prophylaxis 
iii. Explain the testing process 
iv. Offer the test 
Post-test counselling for HIV positive pregnant 
women should include information on the 
following: 
i. Disclosure, partner notification and testing 
ii. Benefits of PMTCT intervention 
iii. ARV 
iv. Nutrition 
v. Delivery 
vi. Infant feeding 
vii. The need for follow-up and adherence 
HIV and Infant feeding counseling All maternity facilities shall provide counselling on 
risks associated with possible MTCT during 
pregnancy, delivery and breast feeding and adequate 
information to limit MTCT if the mother is HIV 
positive, including referrals for family planning 
services.All HIV infected mothers should be 
encouraged to exclusively breastfeed their babies for 
the first 6 months, after which complementary feeds 
are introduced and breastfeeding continues for up to 
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12 months. Breastfeeding should be accompanied 
with maternal ART or ARV prophylaxis and infant 
ARV prophylaxis. 
Modification of obstetric practices When a woman is known to be HIV positive or is 
diagnosed as HIV positive during pregnancy, her 
obstetric and medical care will need to be 
strengthened and modified.  
Administration of Antiretroviral (ARV) 
prophylaxis to mother-child pair 
Pregnancy in the HIV positive woman is an indication 
for ARVs irrespective of CD4, VL or clinical stage 
The time to commence and ARV choice depend on 
the clinical setting: 
Use of Anti-retroviral drugs for therapy (ART) 
ART should be initiated in HIV positive pregnant 
women based on the following criteria: 
a. CD4 Count ≤ 350 irrespective of WHO clinical 
staging 
b. WHO AIDS Stages III & IV disease, irrespective 
of CD4 cell count. 
Use of Anti-retroviral drugs for prophylaxis 
ARV prophylaxis should be provided for HIV 
positive pregnant women who do not meet above 
criteria. They include women with WHO Stages I & 
II AIDS with CD4 of >350cells/ml. 
18 
 
All infants irrespective of type of feeding should 
receive: Daily NVP from within 72 hours of birth to 
6 weeks of age: For babies with weight <2,500g, give 
NVP 10mg or 1ml once daily while for babies with 
weight ≥2, 500g, give NVP 15mg or 1.5ml once 
daily. 
Source: Federal Ministry of Health, (2010, p.7) 
 
In 2016, the PMTCT guidelines were updated to provide for administration of ART to all HIV 
positive pregnant women irrespective of their WHO clinical stage and CD4+ cell count as opposed 
to the previous practice of providing ART only for those with CD4 Count ≤ 350 irrespective of 
WHO clinical staging and WHO AIDS Stages III & IV disease, irrespective of CD4 cell count 
(Federal Ministry of Health, 2016). The new guidelines have also strengthened the provisions on 
family planning services to include offering contraception including emergency contraception to 
all HIV positive mothers in the immediate postpartum period to prevent unintended pregnancy. 
These PMTCT guidelines also form part of the national strategic plan for HIV/AIDS outlined by 
Federal Ministry of Health and NACA (2017), particularly the goal that seeks to Integrate PMTCT 
services by ensuring the provision of one-stop access to ANC, eMTCT, MNCH and family 
planning services. While the PMTCT guidelines provide specific interventions that must be 
followed by health facilities, the strategic plan sets out targets and general interventions activities 
that the guidelines must rely on.  
The uptake of PMTCT interventions reflects both capacities of clinics to provide PMTCT 
services and acceptability of the intervention to clinic attendees (USAID, 2002). This study is 
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concerned with the demand for and uptake of PMTCT services. Despite improvement in coverage 
of these services, progress is insufficient because women and children either do not receive the 
services or are lost to the system before completion of treatment. However, studies have always 
focused on access to the services without considering their use and adherence by HIV positive 
women. Some studies have showg that cultural and ideological factors can influence access and 
utilization of health services (Standing, 1997). Specifically, the most difficult barriers to slowing 
the spread of HIV/AIDS originate from the negative perceptions about HIV that result in shame 
or ostracism and the stigma faced by people with HIV/AIDS (Israel & Kroeger, 2003). Due to 
gender related factors such as inequality, vulnerability and dependency, women are often exposed 
to social ostracism and marginalization which often restricts their access to much needed 
information and services (Gupta, 2002). In particular, women’s relationships with their partners 
may affect their abilities to undergo Voluntary Counseling and Testing (VCT) and adhere to infant 
feeding choices (Israel & Kroeger, 2003). Standing (1997) adds that utilization of health services 
by women is inhibited by their inability to act freely without permission from their husbands or 
senior kin and the fact that health needs of women and girls are often under-valued (Key, 1987; 
Tipping & Segall, 1995, as cited in Standing, 1997).  
Research conducted on women’s inequality in economic opportunities have provided a 
useful basis for an enquiry into utilization of PMTCT services such as those conducted by Barret, 
(1995);  Wilkinson (1996) and World Bank (2001). These studies have failed to link the issues of 
gender with the PMTCT guidelines to track the specific stages where HIV positive women drop 
out of treatment. Most of the current literature on utilization of PMTCT services consider only 
aspects of PMTCT instead of providing analysis of PMTCT use and adherence in its totality as 
provided in the Nigerian Guidelines and Strategic Plans. Furthermore, little attention has been paid 
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to social support and health belief models as explanatory variables for PMTCT utilization and 
adherence. For example stigmatization of HIV positive women may cause weakening support 
which according to Hill, Maman, Grove and Moodley (2015) is an integral health component of 
the adolescent mother-child pair during pregnancy and postpartum. For example, a woman who 
plans to cease breastfeeding at 6 months may choose to carry on breastfeeding due to the fear that 
members of her community will develop negative reaction towards her for rapidly ceasing 
exclusive breastfeeding at six months (Thorsen, Sunby & Martinsen, 2008).  
Given that social support is important for the well-being of HIV positive women, there is 
need to better understand the crucial role played by partners, families and communities and how 
they either provide or fail to avail support to HIV positive women during pregnancy or in their 
postpartum period (Hill et al., 2015). 
1.2 Statement of the Research Problem 
The distribution of PMTCT services in health care facilities of many developing countries is not 
wide and in countries like Nigeria, the level of utilization is often low (Ekanem & Gbadegesin, 
2004). Among women from resource-poor settings, utilization of PMTCT services is unacceptably 
low as demonstrated by some research studies (WHO, 2008; Avert, 2009).  
Studies have also revealed that utilization of some PMTCT services such as Voluntary 
Counseling and Testing (VCT) and infant feeding have proved challenging for some women (Israel 
& Kroeger, 2003).  In the 20th international Acquired Immune Deficiency Syndrome (AIDS) 
conference 2014 held in Melbourne Australia, it was revealed that even in high income countries, 
a significant proportion of PLHIV continue to present late for treatment, thereby reducing the 
effectiveness of ART on preventing HIV infection and consequently morbidity and survival. In 
many circumstances, immediate enrolment in care is hindered because women who are informed 
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of their HIV-positive status are not adequately linked with appropriate services (WHO, UNICEF 
& UNAIDS, 2011).  
Furthermore, a NACA (2014) PMTCT communication strategy highlighted the barriers to 
PMTCT service provision in Nigeria which centered on pregnant women’s low motivation to use 
PMTCT services thereby contributing to increase in HIV positive babies, infant morbidity and 
mortality. In developing countries, governments and donors have invested substantially towards 
PMTCT implementation but there are still HIV positive women who fail to return to clinics for 
follow-up visits and others who do not adhere to the ARV drug treatments prescribed for them 
(Adejumo et al., 2013).  
Reliable figures for PMTCT utilization rates in Nigeria are not available but reports have 
shown that despite adopting PMTCT guidelines stipulated by the World Health Organization 
(WHO), the percentage of women who were counseled and tested for HIV in 2016 was only 34.7 
per cent. Similarly, the percentage of pregnant Women Living with HIV (WLWHA) who received 
Antiretroviral Treatment (ART) for PMTCT in Nigeria was only 32 per cent (NBS & UNICEF, 
2017). Given a corresponding MTCT rate of 22 per cent as reported by (UNAIDS, 2018), an ART 
enrollment rate of 32 per cent is quite low. Therefore understanding PMTCT service adherence 
and utilization is crucial especially in the context of Nigeria where discriminatory social structures 
and stereotypes are entrenched in communities and where women’s level of autonomy in seeking 
health care is often restricted by family members. 
 
1.3 Rationale and Significance of the Study 
Policy makers and health practitioners involved in providing PMTCT services are faced with some 
challenges in implementation of PMTCT guidelines (Nuwagaba-Biribonwoha, 2007; Pai, 2009; 
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Willan, 2004 & Chopra, 2009). Findings from this study will enable health managers to spot 
concerns of women who are rejecting PMTCT services and resolve their needs. This will aid in 
ensuring that PMTCT is integrated into the programming of sexual and reproductive health as well 
as promote fair distribution of health services in Nigeria (United Nations Children’s Fund, 2012). 
Subsequently, this may contribute to improved maternal health, child survival and support for 
Nigeria’s effort to implement the National PMTCT program of 2010-2015 (Federal Ministry of 
Health, 2013). 
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), acknowledged that 
PMTCT is significant for keeping WLWHA alive through treatment, ensuring that the life of their 
babies are saved and aids in the protection of her other children from becoming orphans (UNAIDS, 
2010). This triple benefit characterized by PMTCT, will only be enjoyed by Women Living with 
HIV/AIDS (WLWHA) who are using and adhering to PMTCT services. Understanding PMTCT 
utilization and adherence patterns at each stage of the PMTCT guideline would play a large part 
in maximizing the efficacy of biomedical approaches to HIV prevention. Also, the unmet need for 
healthcare is a startling threat to WLWHA and their quality of life. As such, health care utilization 
as a critical element of wellbeing and a component of human capital is of major interest to social 
development. 
 
1.4 Aim and Objectives of the Study 
This study is aimed at exploring factors that influence PMTCT service utilization and adherence 
by Women Living with HIV/AIDS (WLWHA) in Rivers State, Nigeria. The objectives of this 
study are to: 
1. Understand the nature of adherence and utilization of PMTCT in Rivers State, Nigeria; 
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2. Examine factors that influence decisions of women living with HIV/AIDS to utilize 
PMTCT services; 
3. Examine factors that influence adherence to the PMTCT services by women living with 
HIV/AIDS;  
4. Identify the barriers and challenges to adherence and utilization of PMTCT services. 
1.5 Research Questions 
1. What is the nature of PMTCT service adherence and utilization in Rivers State, Nigeria? 
2. What are the factors influencing decisions of women living with HIV/AIDS to utilize 
PMTCT services?  
3. What are the factors influencing adherence to PMTCT services by women living with 
HIV/AIDS? 
4. What barriers and challenges do WLWHA face in utilizing PMTCT services and adhering 
to PMTCT regimen? 
 
1.6 Main Assumptions 
This study assumes that the Nigerian society is not culturally liberal. As a result, women 
experience stigma resulting from radical religious and cultural beliefs. This affects adequate 
utilization and adherence of women living with HIV/AIDS to PMTCT services. Additionally, it is 
assumed that women often view themselves as inferior and the involvement of male partners of 
women living with HIV/AIDS in PMTCT programs is low. This makes the social support systems 
in Nigeria weak. Also, the beliefs and perceptions of women living with HIV/AIDS about the 
efficacy of PMTCT and the support they receive from family and community influence their 
decisions to utilize and adhere to PMTCT services. 
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1.7 Clarification of Concepts 
Human Immunodeficiency Virus (HIV). HIV is a virus that infects the CD4 cells which are 
certain types of white blood cells and monocytes/macrophages which have important functions in 
the immune system (Pinsky & Douglas, 2009). This research is concerned with women who have 
tested for HIV that are found to be positive and when they found out their HIV status. 
Acquired Immunodeficiency Syndrome (AIDS). This occurs when HIV causes a pattern of 
devastating infections that attack and destroy the CD4 cells that have essential functions in the 
body's immune system (UNAIDS, 2000). This research considers AIDS as the clinical stage of 
HIV positive women when the disease has progressed to the most advanced stage. 
CD4+ Cells and CD4 Count. “The CD4 T lymphocytes; a subpopulation of the 
lymphocytes also known as T helper cells, are coordinators of the body's immune response and 
provide help to B cells in the production of antibody, as well as in augmenting cellular immune 
response to antigens” (WHO, 2007). CD4 cell count is “a laboratory test that measures the number 
of CD4+ T lymphocytes (CD4+ cells) in a sample of blood. It is used to predict HIV disease 
progression and it is one of the factors used to determine when to start antiretroviral therapy 
(ART)” (Harvey, 2013, p.1). CD4 count in this research is an indicator of adherence and utilization 
of ARV drugs for PMTCT. It also includes whether a WLWHA checks her CD4 count and how 
often she checks. 
Antiretroviral (ARV) drug. “ARV drug is used to prevent a retrovirus, such as HIV, from 
replicating. The term primarily refers to drugs used in the treatment or prevention of HIV” 
(Harvey, 2013, p.1). The Nigerian PMTCT guideline of 2010 provides that an indication for 
treatment with ARV is that a HIV positive woman is pregnant irrespective of her CD4 count 
(Federal Ministry of Health, 2010). This research is concerned with the length of time a WLWHA 
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has taken ARV drugs, how often she takes it and whether she takes the required doses without 
skipping.  
Antiretroviral Therapy (ART). This refers to the use of a combination of drugs that are 
preventive and therapeutic to fight off tuberculosis and other diseases which are considered 
common opportunistic infections that are prone to HIV-infected persons (UNAIDS, 2000). This 
study applies the Nigerian PMTCT guidelines which provides that when a HIV positive woman is 
pregnant, ART should be initiated based on the following criteria: 
i. “CD4 Count ≤ 350 irrespective of WHO clinical staging 
ii. WHO AIDS Stages III & IV disease, irrespective of CD4 cell count while, 
iii. ARV prophylaxis should be provided for HIV positive pregnant women who do not meet 
above criteria. They include women with WHO Stages I & II AIDS with CD4 of >350cells/ml” 
(Federal Ministry of Health, 2010, p.37). This research is concerned with the length of time a 
WLWHA has taken ART, how often she takes it and whether she takes the required doses without 
skipping. 
HIV Counselling and Testing (HCT). HIV testing determines the HIV status of a person by 
carrying out a blood test (Pinsky & Douglas, 2009). HIV counselling is the practice whereby health 
care providers and clients engage in a confidential dialogue to inform clients with information 
about HIV and its risks of transmission to enable them make informed decision before getting 
tested for HIV (Federal Ministry of Health, 2010). This research considers HCT as the first step to 
PMTCT utilization and an indicator of how informed pregnant women are about their HIV status 
as well as their ability to take actions that will prevent transmission to their babies. The research 
also considers whether WLWHA have disclosed their test results to their partners or any family 
member. 
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Mother-to-Child Transmission (MTCT). MTCT of HIV is when a child acquires HIV from 
a HIV-positive mother either at the antenatal, labour, delivery or postnatal stage while 
breastfeeding the child (Federal Ministry of Health, 2010). In the context of this research, MTCT 
is an indication of poor adherence to ARV drugs or ART and failure to act on recommendations 
of health care providers.  
Prevention of Mother-to-Child Transmission (PMTCT). This is the provision of ARVs to 
pregnant women as either prophylaxis or therapy throughout their pregnancy, during labour and 
breastfeeding to ensure that their babies are HIV-negative (Federal Ministry of Health, 2010). 
Infants born to mothers who are not taking ARVs during the breastfeeding period should be 
administered ARV prophylaxis for one week after all breast-feeding has been ceased (Federal 
Ministry of Health, 2010). Other important measures outlined by the Federal Ministry of Health 
(2010) include avoiding “obstetric procedures such as chorionic villus sampling, external cephalic 
version, early artificial rupture of the membrane, instrumental delivery and episiotomy where 
possible, as well as active management of the third stage of labor and the use of elective caesarean 
delivery” (Federal Ministry of Health, 2010, p.3). In addition to these, PMTCT in this study 
consists of the continuum of care given to a HIV positive woman from the first antenatal care visit, 
throughout pregnancy and breastfeeding period. These include: HCT, provision of ARV drugs to 
the mother infant pair at post-delivery stage, exclusive breastfeeding of infant for 6 months as well 
as infant follow-up until 18 months post-delivery. 
Exclusive Breastfeeding. This is when infants are not given any other food or liquid 
including water during the first six months after delivery with the exception of medicine, vitamin 
syrup and oral rehydration solution (Khanal, da Cruz, Karkee, & Lee, 2014). In Nigeria, all babies 
born to HIV-positive mothers are encouraged to be exclusively breastfed and during this period, 
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the mothers and their babies should be receiving maternal ART or ARV prophylaxis and ARV 
prophylaxis for the infant (Nigerian Ministry of Health, 2010). Based on this requirement, this 
research considers exclusive breastfeeding as the length of time a HIV positive mother provided 
her infant with only breast milk, whether she introduced any food or liquid at some point and when 
she completely stopped breastfeeding. 
Exclusive Replacement Feeding. Replacement feeding means that during the first 6 months 
after delivery, HIV-positive mothers choose to not breastfeed at all. The infant is only given foods 
and liquids other than breast milk such as commercial or home-prepared infant formula and 
micronutrient supplements (Sethuraman, et al., 2011). This research considers exclusive 
replacement feeding as the length of time a HIV positive mother provided her infant with foods 
and liquids other than breastmilk and whether she introduced breastmilk at any point. 
Mixed Feeding. This is when an infant is initially being breastfed but is soon taking 
supplementary feeds, water or drinks before 6 months after delivery (Saadeh, Henderson & 
Vallenas, 2005). Compared to exclusive breastfeeding, this method of infant feeding is said to be 
associated with a higher risk of HIV transmission to the infant (WHO, 2005). In this research, the 
length of time of exclusive breastfeeding and the time of initiation of supplementary foods are 
considered. 
Utilization of PMTCT. Utilization of a health service is defined as how much of a particular 
health service or services are used by a given population in a specific period of time (Pérez-Cuevas, 
Doubova, Flores-Hernández & Muñoz-Hernández, 2012). This study defines utilization of 
PMTCT as: 
 Visit to health care facility for antenatal care; 
 Taking HIV test;  
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 Health facility delivery.  
Adherence. This is referred to as the act of “taking medications exactly as prescribed or 
following a specific plan of medical care, such as returning for regularly planned follow-up clinic 
visits. Poor adherence to an HIV treatment regimen increases the risk for developing drug-resistant 
HIV and virologic failure” (Harvey, 2013, p.1). This study defines PMTCT adherence as: 
 Returning to health facility for VCT results;  
 Taking prescribed ARVs; 
 Returning for follow-up clinic visits; 
 Providing antiretroviral prophylaxis for infants born to mothers living with HIV; 
 Practicing either exclusive breastfeeding or exclusive replacement feeding. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Introduction 
This chapter provides a review of studies conducted in various settings with varied socio-economic 
conditions. Many of the studies on HIV/AIDS and PMTCT were related to gender, adherence and 
utilization of PMTCT services including studies that illustrate the experiences of women. The 
chapter discussed factors that influenced utilization of PMTCT in the literature and identified gaps 
in the literature for further research. 
2.2 Impact of HIV/AIDS on Women 
Women take the brunt of socio-economic effects of HIV infection and their economic, social and 
cultural dependence on men makes them vulnerable to HIV infection (Albertyn, 2000).Most 
women living with HIV/AIDS (WLWHA) who are in their child bearing age face difficult choices 
about child bearing due to the risk of infecting their children. As care givers, women are usually 
responsible for dying family members and children who have become orphans because of losing 
their parents to HIV/AIDS (Albertyn, 2000). In addition, the socio-economic stressors faced by 
women infected with HIV often exacerbate the negative consequences of HIV which can affect 
their mental and physical well-being. For example, unemployment and inadequate funds to 
transport and feed themselves are significant obstacles to mothers’ access to care and treatment for 
their HIV infected children. 
These challenges are compounded by the feeling which HIV positive women have that they 
are no longer attractive or desirable because of their HIV status. They feel a sense of social 
disapproval of their reproductive rights and often feared that if the community became aware of 
their HIV status, they could lose custody of their children. In a study conducted by Faithfull (1997) 
as cited in Modeste and Majeke (2010), HIV infected women were faced with the impact of grief 
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and feared that they might infect their children through casual contact. Women are also vulnerable 
to HIV infection because they are often economically, socially and culturally dependent on men. 
They are therefore likely to face economic and social hardship in the event that they are abandoned 
by their partners or face violent reactions from them (Modeste & Majeke, 2010). 
In some instances, women find it difficult to freely undertake VCT or reveal their HIV 
status because they know they will be blamed for sexual immorality. For example Pashwana-
Mafuya (2008) contend that women are accused by their in-laws of avoiding breastfeeding in order 
to appear or smell attractive to other men. There is also a belief that the new born baby should be 
given “isicakati” (traditional drink) as their first feed for a couple of days in order to cleanse the 
gut immediately after birth and improve the baby’s stools (Pashwana-Mafuya, 2008). These 
cultural influences on infant feeding choices indicate that some babies born to HIV positive women 
do not receive nevirapine 72 hours after delivery. 
 
2.3 Gender, Health and Socioeconomic Disparities and HIV/AIDS 
“Gender inequalities affect women’s experience of living with HIV, their ability to cope once 
infected, and their access to HIV/AIDS services” (WHO, 2009, p.xii). There is a close link between 
gender equity and economic structures (Moss, 2002). International organizations such as the World 
Bank have promoted gender equity because of the evidence of its positive association with lower 
fertility, better health outcomes and consequently, economic development (Moss, 2002). The 
reasons most frequently cited to explain the inequality and disadvantaged situation of women vis-
à-vis men are related to low levels of education, employment and income (De los Rios, 1993). For 
instance a study by Hutchinson and Mahlalela (2006) in Eastern Cape, South Africa found that 
women who had completed secondary education were five times more likely to use VCT services 
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than women who had little or no education. Similarly, Medly (2004) cites that illiterate women 
were not as likely to share their test results with their partners as women with higher levels of 
education. These authors also found that importantly, stigma affects VCT utilization in females 
considerably more than it affects males. 
Shisana, (2004) asserts that men and women are valued differently. This has a direct 
implication on how much control and access men and women have over the resources available to 
them for protecting their health and that of their families. For example, a study in Tanzania found 
that a potential barrier to accessing VCT services by women is created when they are compelled 
to discuss testing with their partners while the decision made by men to seek VCTis made 
independent of others (Gupta 2000). Shisana (2004) outlines examples of trends observed in 
Lesotho and Swaziland noting that a married woman cannot sign contract for a property without 
permission from her husband because she is considered a legal minor under the guardianship of 
her husband while an unmarried woman remains under her father’s. 
In Mozambique, Shisana (2004) states that wives are subordinates to their husbands who 
are traditionally the heads of households and their properties are held by their husbands. The wife 
has no right to enter into commercial transactions with her property unless she seeks his 
authorization. Similarly, the tradition in Swaziland does not permit a woman to inherit from her 
late husband and she needs either her husband or male relative in order to access land. How then 
will women access health services or reveal their results from HIV test their partners or parents? 
This submissiveness and subordination of women in places like the Swazi society put women at a 
disadvantage in accessing healthcare services including HIV/AIDs treatment. (Whiteside et al., 
2003). 
32 
 
The idea that women are less powerful than men in terms of social, economic and political 
standing gives the impression that women must obey men or their economic support will be 
withdrawn. In a study conducted in South Africa by Dunkle et al. (2004) women whose partners 
were controlling were found to be more likely to say they never used a condom. Since women 
depend more on others for their security in the longer term, “their risk to HIV increases and 
consequently their lack of access to treatment especially PMTCT increases” (Standing, 1997, p.2). 
Therefore apart from economic factors, women’s vulnerability to HIV/AIDS is also attributed to 
cultural practices and expectations (Shisana, 2004). The consequence of inequality between men 
and women in cultural, economic, social and political spheres is that the chances of taking 
HIV/AIDS preventive measures are diminished. Due to the presence of harmful traditional 
practices, passing legislations that seek to foster good gender relations may not be effective enough 
to end gender discrimination (Shisana, 2004). 
 
2.4 Global Targets and Strategies for PMTCT 
Transmission of HIV from mother to child during pregnancy, labor and breastfeeding is 
considered as the leading cause of mortality for mothers and babies in Sub-Saharan Africa and has 
been considered a serious global emergency. Several targets have been set globally for PMTCT of 
HIV. For example, an entire United Nations General Assembly Special Session (UNGASS) which 
was held in June 2001 was dedicated to HIV/AIDS. Its declaration on HIV/AIDS issues resulted 
into a commitment to reduce the percentage of HIV/AIDS infections in infants by 50% in 2010 
through ensuring access to essential prevention, treatment and care services for 80% of pregnant 
women and their children to reduce MTCT (Thorne, Malyuta, Ferencic, Mimica, & Eramova, 
2011). More recently, a Geneva consultation held in November, 2010 is committed to achieve 
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significant improvement in maternal, newborn and child survival through elimination of new HIV 
infections at birth.  
Many studies have outlined strategies for reducing MTCT. For example, Tarakeshwar 
(2008, p.19) states that “usually integrated within a hospital or a community clinic that provides 
HIV care, Voluntary Counseling and Testing (VCT) enables interested individuals to learn their 
HIV status, learn more about HIV, and potentially gain access to HIV care and treatment, if 
available”. Also, attention is being focused in the area of expanding access to VCT in order to 
achieve efficiency in the roll-out of antiretroviral (ARV) therapy for the treatment of HIV disease 
and prevention of mother-to-child transmission (PMTCT) (Baggaley, 2001). It is therefore no 
doubt that the UNAIDS has prioritized promotion of VCT and has made it an essential element in 
its HIV response strategies (Baggaley, 2001). Other strategies that have recorded measurable 
improvement in the efficiency of PMTCT program are: the opt-out approach to VCT, providing 
mothers with ARV as soon as they have been diagnosed and early provision of infant dose 
(Spensley et al., 2009). In addition, Myer et al. (2017) report viral load monitoring as a key 
component of ART services in lower and middle income countries and is part of WHO (2016) 
chapter 4.5.1 PMTCT guidelines. These guidelines emphasize the need to scale up access to 
routine viral load testing at 6 months, 12 months and then every 12 months thereafter. 
The results of a review of PMTCT experience in Georgia conducted by Tsertsvadze et al. 
(2008) showed that among 14 women who were pregnant and participated partially in PMTCT, 2 
children were HIV-infected. There was no case of HIV transmission among 12 pregnant women 
who were given AZT at around 7 months into the pregnancy and among 32 women who received 
full prophylaxis therapy. Similarly, Mofenson et al. (2011) used Kaplan-Meier methods to estimate 
the rate of transmission and rate of death from birth until 2 years postpartum. These rates were 
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then compared among subgroups defined based on the CD4 cell count and viral load of the mother. 
Their findings provided evidence that in a resource-limited setting, it is safe and feasible to give a 
triple-antiretroviral regimen for PMTCT to a HIV positive woman from late pregnancy until she 
has achieved 6 months of breastfeeding. This approach is part of the biomedical interventions 
mentioned by Tarakeshwar (2008) for preventing HIV/AIDs from being transmitted to babies 
during pregnancy or at postpartum.  As opposed to biomedical interventions, a more public health 
approach was proposed by Sam-Agudu et al. (2017). This involves structured mentor mother 
programs to ensure retention in care and viral load suppression for mothers at postpartum. Using 
logistic regression model, they found that exposure to structured mentor mother support was 
associated with higher odds of retention and viral suppression at 6-month postpartum than routine 
peer support. 
Administering ART during and after childbirth also promises to produce the greatest 
prevention success in PMTCT (Hoffman, 2008). Following delivery, uninfected infants remain at 
risk of HIV infection via breast feeding. Mothers in industrialized countries who are HIV infected 
are usually advised to practice exclusive formula feeding so that the risk of HIV transmission from 
breast milk will be totally eliminated (Hoffman, 2008). Arendt (2007) as cited in Hoffman (2008) 
argued that the most efficacious way of preventing HIV transmission at postpartum is by advising 
the mother to use ART through-out the breastfeeding period. 
 In its recommendation, WHO (2009:xii) outlines that where available, HIV-positive 
mothers especially for women living with violence should be linked with social and legal services, 
support groups, income generation and food security schemes/initiatives, home and community-
based care programmes and orphan care(WHO 2009). A case of successful implementation of 
HIV/AIDS responses is exemplified in Brazil’s battle against stigma and discrimination. Brazil 
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prioritized stigma and discrimination in their response to HIV/AIDS and achieved considerable 
success through government and civil society partnerships (Berkman, Garcia, Munoz-Laboy, 
Paiva & Parker, 2005). These responses were buttressed by Vrazo, Sullivan and Phelps (2018) 
who outlined five related strategies for elimination of MTCT of HIV by 2030 which are mostly 
public health approaches. A notable public health strategy is the implementation of novel service 
delivery models such as community treatment groups. 
In addition rapid scale-up in the free drug program in São Paulo was achieved through a 
form of universal distribution which allowed for the creation of numerous more access points to 
treatment. Brazil’s capacity to locally manufacture pharmaceuticals paved way for a financially 
viable program of universal and free access (Berkman et al., 2005). For these reasons, Brazil’s 
program of universal and free access to ART has been recognized as the best internationally known 
policy and all public health response to the HIV/AIDS epidemic use it as a model ART roll-out 
program (Galvao, 2008). 
Benatar (2004) argues that countries like Brazil, Uganda, and Botswana have so long 
provided evidence of exemplary leadership on HIV and AIDS which can be emulated by less 
successful countries. However, it is necessary to note that interventions found effective in one 
country may not be equally successful in other countries. For example Muko (2004) argues that 
although the infant feeding guidelines in HIV/AIDS settings provided by WHO and UNAIDS are 
quite clear, formula feeding may not be economically and socially viable in the context of low 
income countries because it entails infectious and nutritional health risks in such areas. In essence, 
the social, behavioral, biomedical and public health interventions outlined for PMTCT may not be 
culturally transferable to some settings and the level of infrastructure and resources may not be 
available. 
36 
 
In a South African study conducted by Sibeko (2005), mothers valued the use of traditional 
herbal preparations (Muthi) for their new born babies thus hindering the ability to practice 
exclusive breastfeeding. None the less, the WHO (2010) provides that there is a chance of reducing 
the risk of MTCT down to between only 2 and 5 per cent if modern PMTCT strategies of testing, 
provision of ARV, modified obstetric and infant feeding practices are adopted. However, while 
the developed world which has lower prevalence rates has dropped MTCT to less than 2 per cent 
with the implementation of universal VCT, ARV prophylaxis, elective Caesarean section, and the 
avoidance of breastfeeding, Sub-Saharan Africa has the heaviest burden of maternal HIV infection 
and MTCT suggesting that these strategies, are still limited both in scope and reach in most of the 
less developed world (FMOH, 2003; WHO, 2010). 
 
2.5 PMTCT Policies and Challenges of the Nigerian Health System 
In 1998, the Federal Ministry of Health (FMOH) in Nigeria developed the National AIDS Control 
Program (NACP) which was expanded in 1991 to include sexually transmitted infections (STIs). 
The new National AIDS and STDs Control Program (NASCP) developed guidelines on key 
interventions that seek to manage STIs and HIV/AIDS components such as VCT and PMTCT, 
ARVs administration, including the treatment of opportunistic infections and home-based care 
(Nasidi, 2006). 
Other programmes developed in Nigeria since the restoration of democracy in 1999 such 
as National Action Committee on AIDS (NACA) did not have specific focus on PMTCT. It was 
not until 2003 that the first PMTCT program was initiated. In line with global targets, this 
programme set out to reduce MTCT by 50 per cent. The AIDS prevention initiative in 2003 and 
2004 provided support to 5 of the 11 federally established PMTCT sites (Nasidi, 2006). In 2011, 
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Nigeria endorsed the Global Plan for PMTCT which aims at ensuring a 90 per cent reduction in 
new HIV infections and 50  per cent reduction in maternal deaths caused by AIDS(Sagay, 2013). 
More recently the National HIV/AIDS prevention plan 2014-2015 was developed. This 
policy states that in order for prevention strategies of countries to be optimally realized, prevention 
initiatives must be comprehensive and rolled out in such a way that there is access, frequent use 
and quality on a national scale (NACA, 2013). However, this policy is undermined by the lack of 
programmatic approaches that increase utilization and adherence rates and not much effort is made 
by the Nigerian government to track progress in this respect. A lot of emphasis is placed on access 
and increasing quality while neglecting the issue of utilization and adherence to the HIV/AIDS 
services. For example, the policy acknowledged that non-adherence to national testing algorithm 
was a challenge and committed to addressing the risk factors that disproportionately expose 
women and girls to the HIV epidemic which emanate from social, economic and cultural barriers.  
However, this commitment has not been accompanied by practical strategies for ensuring 
adherence and utilization. Similarly, the National HIV/AIDS Strategic Plan of 2010-2015 paid 
little attention to utilization rates. Although antiretroviral coverage was mentioned, effort was not 
made to track its progress from previous years and to know the utilization and adherence patterns 
among pregnant women living with HIV. These have undermined Policies on HIV/AIDS and 
PMTC thereby putting Nigeria among the 21 Sub-Saharan African countries that lag behind global 
targets with 22 per cent MTCT rate in 2016 and among countries that have the highest number of 
WLWHA in need of PMTCT services (UNAIDS, 2018). 
The primary purpose of the national health system of a country is to improve health and 
this is achieved by all the organizations, institutions, resources and people responsible for 
managing it (John-Langba, 2013). Three tiers of government are responsible for providing health 
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care in Nigeria namely: the federal, state, and local government (Adeyemo, 2005). With support 
from state ministries and private medical practitioners, 774 Local Government Areas provide 
primary health care at the villages, districts and local government areas (Omoruan, 2009). 
Secondary health care is primary health care that is managed by states ministries of health who are 
also responsible for patients referred from the primary level of the health system. Provision of 
laboratory and diagnostic services, rehabilitation and other services is done at this level of health 
care (Osian, 2011). The Federal government in conjunction with voluntary, non-government 
organizations and private practitioners is responsible for the provision of tertiary health care 
(Adeyemo, 2005). However in Nigeria, the Primary healthcare (PHC) system which is expected 
to be the foundation of the country’s health system is facing difficulties in providing basic 
healthcare services to the population. This is due to problems of poor budgetary allocation, 
decaying and poor infrastructure, poor governance structure, poor service delivery and poor health 
worker performance (Aregbesola & Khan, 2018). 
John-Langba (2013) emphasises that a well-functioning health system delivers quality 
services to all the citizens of a country at any time and place as needed. This includes a well-trained 
and adequately paid workforce; reliable information on which to base decisions and policies; well-
maintained facilities; and logistics to deliver quality medicines and technologies (John-Langba, 
2013). A review of the health care system in Nigeria has shown that over the last decade, there has 
been huge development in the health care sector although there are a lot of gaps and challenges 
(Adeyemo, 2005; Omoruan et al., 2009). In Nigeria, the process of drugs procurement has been 
marred by unavailability, inadequate storage facilities, poor transportation and the presence of 
unqualified personnel thus hindering the system from achieving its goals (Adeyemo, 2005).  
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One of the most significant obstacles to progress in providing ART in hospitals is capacity. 
With current staffing levels in Nigerian hospitals, continuing the roll-out of ART to those already 
on treatment may not be sustainable because most of the treatment is provided through hospitals. 
Apart from understaffing, medical equipment, buildings and other basic infrastructure are not 
sufficient to accommodate the number of people seeking HIV/AIDS related care. This translates 
to reduction in the quality of services provided to persons living with HIV/AIDS thus hindering 
the achievement of goal of achieving universal access to HIV/AIDS related care. 
Another component of well-functioning health systems mentioned by John-Langba, (2013) 
is a robust financing mechanism. The public healthcare sector in Nigeria has been faced with the 
challenges of inadequate funding of hospital pharmacies and the problem of medication and 
hospital materials being out of stock. Other factors are that doctors pay greater attention to their 
private clinics and refer patients to private diagnostic centers, bribes-demand by hospital staff, 
diagnostic tests done even when unnecessary and truancy on the part of doctors and other health 
workers.   
Agboghoroma (2013) further summarized the health system challenges faced by the 
Nigerian government which have affected the provision of PMTCT services. Firstly, the author 
noted that the PMTCT program in Nigeria was initiated as a pilot program which was to be 
executed by tertiary institutions with the intention of decentralizing it to secondary hospitals and 
primary health care facilities. However, the state and local government levels were reluctant to 
buy-in thereby slowing down the decentralization process. Challenges of weak health systems; 
limited human resources especially in rural areas and low utilization of maternal and child health 
care services have relegated the nation’s health system to the background resulting in high 
mortality rate and low life expectancy (Agboghoroma, 2013).  
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 Furthermore, despite instituting many programs and projects such as The National 
Strategic Health Development Plan (NSHDP 2010-2015), the National Health Act (2014), Basic 
Health Social Scheme (BHSS), Primary Health Care Development Agency (PHCDA), National 
health outcomes in Nigeria continue to worsen. For example, the most recent report from the WHO 
database states that Nigeria’s Maternal Mortality Ratio (MMR) is 814/100,000 live births which 
makes Nigeria the worst after Chad, Central African Republic and Sierra Leone and against the 
Sustainable Development Goal (SDG) global target of 70/100,000 live births by 2030. In Nigeria, 
the proportion of births attended by skilled health personnel is only 35% while child mortality is 
108.8 which is very high compared to the SDG target of 25 per 1000 live births. Malaria incidence 
per 1000 population is 380.8 making Nigeria the highest after Burkina Faso and Mali. With 140, 
542 people in need of treatment for neglected tropical diseases, Nigeria scored the lowest in terms 
of SDG goal 3.3 which seeks to end the epidemics of AIDS, tuberculosis, malaria and neglected 
tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases by 
2030. These startling statistics are indicative of the poor status of Nigeria’s health sector which is 
fraught with huge disparities in health coverage and outcomes.  
Nigeria’s health statistics shows that the country ranks low in terms of access to healthcare 
delivery. Nigeria was placed at the 140th in the 2015 global health care ranking out of 195 countries 
and territories from 1995 to 2015, which was based on qualification of personal access and quality 
(The Guardian Newspaper, 2017). Out of 100 points on the healthcare Access and Quality Index, 
Nigeria reportedly scored only 51 points (Guardian Newspaper, 2017). Despite this, the Nigerian 
government continues to rely heavily on user charges and NHIS to finance health systems which 
have significant implications for livelihoods of poor people. Direct charges for health care at the 
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point of use (user fees) or out of pocket payment (OOP), further limits access to health services 
and pushes households into poverty.  
In addition, evidence has shown that high dependency on out-of-pocket (OOP) payments 
in the form of user charges and co-payments are regressive as they disproportionately affect the 
poorest in society (Adeyemi & Nixon, 2013). This therefore challenges the underlying tenets of 
equity within healthcare system. Consequently, poor health seeking behavior occurs among the 
poorest quintiles of the population. Therefore, in line with the global health policy agenda, the 
objectives of equitable access, high quality services, and broader social protection, Nigeria has 
become under sustained social pressure to develop some urgent measures for protecting poor 
families from the negative implications of unaffordable health care payments (Chuma & Maina, 
2013).  
 As explained by Mojekwu (2005), the factors responsible for maternal deaths can be related 
to socio-economic, medical, reproductive and unwanted pregnancy. In many instances, women 
attend antenatal clinics but choose to deliver at home, church or by traditional birth attendants. 
These are termed as individual level factors that can be responsible for high mortality as explained 
by some researchers (Igberase & Ebeigbe, 2007). A study by Muoghalu (2010) found that due to 
illiteracy, poor knowledge and exposure level of income and nutritional status of many women is 
being affected. Consequently, this reduces their ability to access skilled birth attendance. There 
are also situations where women showed up at hospital emergency with numerous complications 
without ever attending antenatal care (Guerrier, Oluyide, Keramarou, & Grais, 2013).  
According to Mojekwu and Ibokwe (2012), low attendance of skilled birth or delivering 
outside of a health facility have grave implications for PMTCT. Agboghoroma (2013) adds that 
Nigeria’s high MTCT rate is largely due to women’s failure to attend antenatal and deliver in 
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modern facilities and other factors. These women who do not use these services are not aware of 
their HIV status and are therefore not benefiting from PMTCT services provided. Also, women 
who fail to deliver at health facilities would not know their children’s HIV status and would miss 
out on life saving antiretroviral drugs for their infants and breastfeeding counselling.   
2.6 Barriers and Challenges to PMTCT Utilization and Adherence 
Governments are increasingly focusing on strategies to eliminate MTCT. While this is welcome, 
efforts are insufficient because of the absence of uniform or universal PMTCT programs 
(Kellerman et al., 2013). A study on evaluation of PMTCT services in Kwazulu-Natal South Africa 
by Horwood et al. (2010) discovered that the problem with PMTCT interventions is not high 
coverage during pregnancy and delivery but poor follow-up of mothers and infants. 
When PMTCT services are poorly integrated into routine care, barriers to accessing post-
delivery services is likely to be created. In some instances, barriers in access are created when 
health workers are not clear about their roles and record keeping is poor. The Kaplan-Meier 
survival analysis and the log rank test was used by Deschamps et al. (2009) to describe the PMTCT 
program in Haiti. Infants who experience early pediatric diagnosis and treatment with ARV are 
said to have improved survival. In developed countries, significant progress has been made with 
PMTCT. For example, there has been a dramatic reduction in the rate of MTCT to 1 per cent due 
to increase in provision of ART to 190 per cent of pregnant women living with HIV (Lazuriaga & 
Sullivan, 2005).  
Several studies have shown that in developing countries, there has been progress achieved 
in some settings while others are experiencing severe health system challenges which have reduced 
the effectiveness of PMTCT programmes. For instance Oladokun, Ige and Kikelomo (2013) 
assessed HIV prevalence in infants and mothers’ use of PMTCT services in clinics where routine 
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immunization is provided in Ibadan, Oyo state in the South Western Region of Nigeria. Using a 
cross-sectional design, they found that the rate at which infants attending clinics are exposed to 
HIV is low and HIV testing was received by more than three quarters of women who used 
conventional health service during their first pregnancies. However, in other settings in Nigeria 
the effects of PMTCT programmes are sub-optimal. To illustrate, Inegbenebor, Umuemu and 
Aigbokhai (2012) conducted a study in 30 randomly selected primary health centres in Edo State, 
Nigeria. The study was retrospective and was aimed at investigating the services provided for 
maternal health care using data collected through antenatal booking records, maternity and 
PMTCT services between 2007 and 2010.The authors found no evidence of VCT or PMTCT 
service provision in an entire senatorial district of Edo State, Nigeria. This is in contrast to South 
Africa where PMTCT services are offered in all public hospitals. 
Furthermore, uptake of VCT constitutes a major challenge to PMTCT implementation. A 
study conducted by Peltzer, Mosala, Dana and Fomundam (2008) highlighted that despite 
providing information about HIV and HIV testing to almost all the women, more than half of them 
(42%) had not been tested and their HIV status remained unknown and only 57% of the HIV-
infected women received nevirapine. This was said to be associated with quality of counselling 
and low encouragement of self-medication with nevirapine tablets at the on-set of labour. In 
another study conducted by Nigatu and Woldegebriel (2011) in Ethiopia, mothers who were 
known to be HIV positive and infants who were known to have been exposed to HIV were 
investigated. It was found that only 53% and 48% respectively received ARV prophylaxis. It was 
found that there was an 11.6 per cent coverage of ARV among the HIV positive mothers while for 
their babies, HIV prevalence rate was 8.4 per cent assuming that HIV prevalence was constant.  
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Another study from the North Central Region of Nigeria was conducted by Anigilaje, 
Dabit, Ageda, Hwande and Bitto (2013) identified some of the risk factors that are likely to predict 
MTCT of HIV. Using bivariate and multivariable logistic regression models, they found an 
independent association of HIV transmission with certain factors such as:  Absence of episiotomy 
at delivery, mothers and their babies receiving ARVs after 72 hours of life, practice of mixed 
feeding, mothers with high viral load ranging between 1001-10,000 copies/ml and children 
presenting for the first time when they are at the age of 12 months or more.In a study conducted 
by Sibeko et al. (2005) in South Africa, mothers valued the use of traditional herbal preparations 
(Muthi) for their new born babies thus hindering the ability to practice exclusive breastfeeding.  
In a cross-sectional qualitative study conducted by Buregyeya et al. (2017), to investigate 
what facilitates or prevents uptake and adherence to ART by pregnant WLWHA in Uganda. A 
content thematic analysis approach showed that the major motivator for uptake and adherence was 
the desire by WLWHA to have babies that are HIV free. WLWHA were found to miss their doses 
completely and skip clinic appointments although family, peer and partner support greatly 
improved adherence. Other barriers revealed in the study centered on fear of HIV status disclosure, 
big size of the ART drug and its side effects as well as HIV stigma which prevented transition 
from antenatal care to HIV chronic clinics. 
A similar study conducted in Kenya by Thomson et al. (2018) explored barriers to 
utilization and adherence to PMTCT throughout the pregnancy and postpartum periods using focus 
group discussions and in-depth interviews. The authors found that female participation in PMTCT 
services is hindered by perceived hazards in the home, community, and clinic environments. This 
is because before following recommendations of health providers, women have to weigh the risks 
and benefits of PMTCT interventions in order to maintain confidentiality and their relationships 
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with partners and community. Another recent study conducted by Omonaiye, Kusljic, Nicholson 
and Manias (2018) conducted a systematic review to examine the factors that enable or prevent 
adherence to medication by WLWHA in sub-Saharan Africa. They revealed that the factors that 
limit administration of ARV medication to WLWHA during pregnancy include stigma, cost of 
transportation, food deprivation and a woman’s disclosure or non-disclosure of her HIV status to 
a partner, family and the community.  
2.7 Factors Influencing Utilization and Adherence to PMTCT Services 
So far, research has established that MTCT amongst women living with HIV/AIDS can be reduced 
through treatment with short-course ARV especially for HIV positive mothers who are 
breastfeeding. However, Mofenson & Mclntyre (2000) cite that a woman cannot make informed 
choices about preventative interventions unless she knows her HIV status also stating that while 
initial acceptance of HIV testing is high, many women fail to return for the results of their tests. 
Mclntyre et al. (2008) also contend that it has become more difficult to deliver interventions for 
PMTCT due to key factors like low VCT uptake and MTCT through breastfeeding which continue 
to drive failure. The reasons mostly cited for women refusing to test for HIV are stigma and 
discrimination and the fear of being harassed, abandoned or murdered as a result of their HIV 
status. Also, in some settings, families have to travel long distances to access clinics and with few 
resources thereby limiting access to ART. It is even more difficult and expensive to access 
transport to clinics when there is an emergency (Skinner et al., 2005). In addition, these authors 
cite that infant feeding becomes more complicated for families living in areas with poor 
infrastructure who lack access to clean water. 
One study conducted by Kasenga, Hurtig and Emmelin (2010) sought to explore 
experiences in the use of PMTCT by rural women in Malawi using a purposively selected sample 
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of 24 HIV positive women. In-depth interviews showed that willingness for HIV testing depends 
on perceived susceptibility of the women to HIV and for protection of their children from getting 
infected. Some women especially those whose sexual partners were aware of their status failed to 
return for treatment because they were afraid of being economically bankrupt and the potential of 
facing domestic violence. The study also identified stigma associated with the administration of 
Nevirapine for babies. It showed that women who didn’t return to deliver in the hospital were 
either sick, too far from the hospital, or lacked support and were afraid of the expenses involved. 
Focus group discussions and in-depth interviews were used by AED (2011) to assess 
peoples’ levels of knowledge, awareness and barriers to the use of PMTCT by pregnant women 
with HIV/AIDS in four regions in Tanzania.  Women fail to utilize health facilities or TBAs at the 
time of labour because of fear of negative attitude from health care staff, delay in receiving 
treatment, difficulties in transportation to health facilities and related costs. Participants in the 
study considered breast milk to be nutritious but found exclusive breastfeeding difficult to practice 
especially for working mothers and those with inadequate milk. There were mothers who viewed 
that water was supposed to be given to babies for quenching thirst while others were pressured by 
family members and who could easily stigmatize them as being HIV positive. Non-breastfeeding 
was not commonly practiced in the study area because of its association with being HIV positive. 
Iwelunmor et al. (2014) conducted a review of empirical studies that reported peoples’ 
perceptions towards PMTCT, influencing factors of actions and decisions towards PMTCT service 
uptake such as availability of enablers/resources as well as the role of families and communities 
in Nigeria. The findings highlighted that unavailability of accessible and acceptable resources at 
affordable price have a negative influence on people’s decisions and actions towards PMTCT in 
Nigeria are negatively influenced by lack of available, accessible, acceptable, and affordable 
47 
 
resources. Also, uptake of PMTCT services specifically decisions on whether or not to disclose 
sero-positive status, family planning and infant feeding choices are influenced by family contexts. 
In a cross-sectional study, 52 women who were enrolled in a PMTCT programme were 
interviewed by Eide et al. (2006) using a structured questionnaire. It was found that the most 
important consequence of participating in PMTCT program was that women experienced difficulty 
in breast feeding. Also, women tend to withhold their HIV status from others, meaning that only 
a few people influence their decision to take part in PMTCT programmes. Okoli and Lansdown 
(2014) conducted a critical literature review of 12 studies that used primary research to explore 
why PMTCT in Malawi and Nigeria either failed or did not achieve the desired outcomes. Socio-
economic and socio-cultural factors were the most notable barriers found in their review followed 
by inadequacy of male partner involvement, how PMTCT is organized and inefficiency of health 
workers. 
In order to investigate the operational factors that predict complete breast feeding cessation 
(CBC) after 24 weeks of Exclusive Breastfeeding (EBF) and its feasibility, Goga et al. (2009) 
conducted a study in three routine PMTCT sites in South Africa. It was a prospective observational 
cohort study that used univariate and Kaplan–Meier Survival analyses, logistic and cox regressions 
to establish that it is uncommon to find CBC by 24 weeks due to lapses in the PMTCT program.  
Predetermined social, economic, and environmental criteria seem to have no relationship with 
success. Henry and Carlson (2005) conducted a study to learn why women attending ANC clinics 
either participate or fail to participate fully in HIV counseling and testing and why those who test 
positive receive or fail to receive ARV prophylaxis at a health center in Georgetown. Based on 
review of records from the health facility, observation of clinical practice and in-depth interviews, 
they found that the most notable reasons why HIV positive women did not receive nevirapine at 
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delivery were related to inability of the women to arrive at the hospital in time and consistent use 
of the ANC clinic card system.  
Sam-Agudu et al. (2014) in their formative research examined barriers to uptake, access, 
acceptability and retention of PMTCT service as well as the experiences of mentor mothers 
providing support for PMTCT clients in rural North Central Nigeria using focus groups and key 
informant interviews. Money for transportation to PHC, poor attitude of health care providers, 
irregular supply of drugs and test kits, uncertainty of 24/7 emergency services, non-awareness of 
clients, confidence in the PHC services available and high level of HIV stigma at the community 
level were cited as the main barriers to uptake, access and utilization of PMTCT services. 
 A more recent study by Nabasirye, Mawa and Ayebare (2019) have also explored the level 
and factors influencing adherence to infant’s NVP prophylaxis regimen at six weeks of age. 
Results from the bivariate analysis and binary logistic regression model showed that maturity of 
the mother and her perceived benefits of administering NVP to the infant are important positive 
drivers of optimal adherence. Similarly, Zegeye, Mbonigaba and Dimbuene (2018) used 
multivariate regression model, Poisson and negative binomial regression models were applied to 
identify significant factors associated with PMTCT service utilization. They found that the 
significant factors associated with low PMTCT service utilization are long walking distance, low 
household income and living in a rural setting. Using exploratory qualitative research, Ankrah 
(2018) identified the health system factors influencing delivery of EID services and the barriers to 
the use of EID services among HIV positive mothers. Some of the challenges identified were 
inadequate staff, transportation challenges, long turnaround time for the return of PCR results, 
inadequate and frequent breakdown of PCR machine. Availability of DBS cards, adoption of task 
shifting strategies and positive attitudes of health workers served as facilitators. In addition, 
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maternal factors such as denial of HIV status, lost to follow up in the EID process, dependency on 
significant others and consequences after disclosure of HIV status were factors that served as 
barriers to mother’s utilization of EID services for their exposed infants. 
2.8   Stigma and Discrimination 
Decock et al. (2002) mention that the potential effect increased access to HIV/AIDS care and ARV 
drugs on improving prevention efforts in Africa has not yet been realized. Yet, it is a topic of 
international discussion at the high-level. Chopra (2009) notes that this is attributed to avoidable 
factors at family levels such as delays in seeking care. The reasons why women refuse to seek for 
care are the fear of being stigmatized or discriminated based on their HIV status. According to 
Decock et al. (2002, p.68), “stigma emerged universally and early on as a powerful, pernicious 
force that is an important barrier to prevention efforts”. 
Similarly, Amuzu (2008) states that people often fail to seek treatment for HIV/AIDS due 
to fear of being discriminated against. In certain instances, people living with HIV face rejection 
by friends, colleagues and may even experience eviction by their families. Furthermore, the 
practice of replacement feeding is stigmatized. Women opting to feed their children through 
replacement feeding are stigmatized in numerous cultures thereby complicating adherence by 
women who prefer to feed their children through this means. Identifying them as being HIV 
positive may result in stigma with consequences such as facing ostracism and expulsion from their 
family members (Horvath et al., 2010). Having acknowledged the link between stigma and the 
workings of social inequality, Parker and Aggleton (2003) argue that it is important for countries 
to consider the broader issues of social exclusion of individuals and how it is created and reinforced 
in different settings. This will enable them to properly understand stigma and discrimination in 
HIV/AIDS or issues related to it. For example in some settings, women’s fear of disclosing their 
50 
 
serostatus is largely due to the possibility of being stigmatized as promiscuous or as sex workers 
(Parker et al., 2002). 
Additionally, Parker et al (2002) report on a symposium where it was noted that stigma 
associated with HIV/AIDS is increased through religious doctrines which promote certain moral 
and ethical positions regarding sexual behavior, sexism and homophobia. They deny the realities 
of HIV/AIDS and stigmatize those infected as sinners who deserve punishment thereby creating 
fear of disclosing sero-status to those who are likely to provide support. Families and communities 
often display their HIV/AIDS-related stigma and discrimination through blaming, scapegoating 
and even punishing those infected. In some communities, those who are perceived to be infected 
with HIV are often shunned or gossiped about. In more extreme cases as seen in reports from South 
Africa, Brazil Thailand and India, violence and HIV/AIDS related murders occur (Nardi & Bolton, 
1991 as cited in Parker et al., 2002). 
In the context of PMTCT, Peltzer et al. (2018) evaluated the impact a multicomponent, 
behavioural, prevention of mother to child transmission (PMTCT), cluster randomised controlled 
trial on HIV stigma reduction among perinatal HIV infected women in rural South Africa. 
Longitudinal analysis showed that increases in stigma from baseline to 12 months were associated 
with being unemployed, having been diagnosed with HIV before the current pregnancy, and 
alcohol use. Lower stigma scores were associated with participation in the intervention, greater 
male partner involvement, and consistent condom use. In a similar vein, Spangler et al. (2018) 
explored these issues among self-disclosed couples living in southwest Kenya. Their textual 
analysis of in-depth interviews showed that stigma continues to restrict full participation in 
community life and limit access to care by promoting fear, isolation and self-censorship. In another 
study, Monteiro, Villela, Soares, Pinho and Fraga (2018) analysed how pregnant women living 
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with HIV/AIDS (PWLHA) experience and cope with AIDS stigma and found that stigma is still 
predominant despite a non-disclosure law guaranteed by the government. The study therefore 
suggested that however, the silence surrounding HIV diagnosis perpetuates the psychosocial and 
structural mechanisms that reproduce stigma. 
2.9 Poverty and HIV/AIDS 
The situation of women is such that have longer working hours and yet 70% of the world’s poor 
are women. They acquire less education than men and their life expectancy is lower (Gilbert & 
Walker 2002). These authors outline the situation in South Africa saying that on average, the 
amount earned by women is between 72 and 85 per centof the amount earned by men who have 
similar education. The authors also reported that low skilled and low paid occupations are highly 
pre-dominated by women with only 22 per cent of women having manager positions.  
Whiteside (2002) posits that although a simple causal relation has not been established 
between the epidemic and poverty, HIV prevalence is highly correlatedwith unequal distribution 
of income. By now it is widely accepted that people, households, communities are impoverished 
by the HIV/AIDS epidemic. As such household income is affected thereby limiting access to the 
hospital where HIV/AIDS care and treatment can be received. Horvath et al. (2010) assert that due 
to poverty, formula feeding and other breastmilk substitutes may not be affordable to many 
mothers. More importantly, the use of replacement feeding in resource poor regions increases the 
risk of diarrhoea because clean water may not be accessible in such areas. As such, using formula 
feeding to protect infants against the risk of infecting HIV may result in placing the same infants 
at risk of getting sick and dying from other infections (Horvath et al., 2010). 
Recent studies have also considered the role that poverty plays in HIV/AIDS service 
utilization. In the context of PMTCT, Yourkavitch et al. (2018) used qualitative research, to map 
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out how the effects of poverty, gender, and health systems on women’s participation in PMTCT 
services. They found that the effect of antiretroviral therapy (ART) use, service design and quality, 
stigma, disclosure, spouse/partner influence, decision-making autonomy, and knowledge about 
PMTCT tend to influence psychosocial health, which in turn affects women’s participation in 
PMTCT services. In a study by Brittain et al. (2018), disclosure over time during pregnancy and 
postpartum and the influence of social and economic circumstances was explored using Mokken 
scale analysis. It was observed that the impact of pregnancy intentions and poverty on disclosure 
to a male partner is often modified by relationship status. Another study by Achebe et al. (2018), 
included socio-economic barriers such as poverty and home deliveries as a barrier to retention of 
mother-baby pairs in PMTCT programs. This is among other factors like long waiting times, 
stigma and discrimination, insufficient disclosure support, and poor family and/or spousal support 
as well as other structural and biomedical constraints.  
2.8 Conclusion  
The studies on PMTCT often focused on utilization and adherence to some aspects PMTCT 
without considering a holistic view of the entire PMTCT cascade. This presents a substantial gap 
in available literature because there is a dearth in literature on factors that influence utilization and 
adherence of PMTCT services at each stage of the PMTCT cascade. Regardless of the methods 
used, capturing one stage of PMTCT and leaving out the others may not allow the researcher to 
pin-point the particular stages of PMTCT where WLWHA tend to drop out. This has the effect of 
limiting the extent of public health solutions that can be proffered to improve utilization and 
adherence.   
Similarly, Most studies conducted on PMTCT have focused on the lived experiences of 
women who were HIV positive without considering the public health approached that may increase 
consistency with the use of PMTCT services. Although this aspect of PMTCT research has the 
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likelihood of revealing salient policy implications, available literature has not considered the 
factors that can increase compliance with the PMTCT services provided in hospitals including how 
to ensure that patients attend follow up visits through antenatal to delivery and postpartum. This 
presents a gap in literature related to policy responses that may enable WLWH use PMTCT 
services more efficiently. 
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CHAPTER 3 
THEORETICAL FRAMEWORK 
3.1 Introduction 
Sutherland (1976,p. 9) as cited in Wacker (1998, p. 364), defines theory as “an ordered set of 
assertions about a generic behavior or structure assumed to hold throughout a significantly broad 
range of specific instances”. In other words, theories are important underlying assumptions about 
a study. Theories provide explanation on why and how specific events are caused by specific 
relations (Wacker, 1998). This study is guarded on two theories namely health belief model and 
social support theory. It is expected that these theories will explain how individual characteristics 
influence women’s decisions to utilize PMTCT services or why they fail to use them. 
3.2 Health Belief Model 
The Health Belief Model (HBM) was developed by a number of social psychologists namely: 
Irwin M. Rosenstock, Godfrey M. Hochbaum, S. Stephen Kegeles, and Howard Leventhal 
(Carpenter, 2010; Glanz, Rimer & Viswanath, 2008). The theory was developed in the 1950s 
making it one of the first models of health behaviour (Glanz & Bishop 2010). In HBM, the main 
assumption is that the determinants of health behaviour of people are their beliefs about a disease 
or perceptions of it and the strategies that can be taken to decrease its chances of occurring 
(Rosenstock, 1974; Glanz, 2008). 
HBM recognizes four main constructs which are: perceived seriousness, perceived 
susceptibility, perceived benefits and perceived barriers. These constructs are further explained as 
follow: 
i) Perceived seriousness proposes that individuals who perceive a health problem to 
be serious are more likely to prevent its occurrence or reduce severity of the health problem 
(Janz & Marshall, 1984; Rosenstock, 1974; Glanz et al., 2008).  
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ii) Perceived susceptibility is concerned with the assessment by an individual of the 
risks associated with a particular health related problem. HBM assumes that when individuals 
perceive susceptibility to a health problem, they are more likely to engage in behaviours that 
will reduce their risk of developing the health problem (Rosenstock, 1974).  
iii) While perceived seriousness and susceptibility are jointly termed perceived threat, 
Glanz et al. (2008) posits that perceived benefit relates to assessment by an individual of the 
value or efficacy associated with a particular health problem. HBM proposes that regardless of 
the objective facts of the effectiveness of a health behaviour, an individual is likely to engage 
in that particular health behaviour when he or she has confidence that susceptibility to a 
particular health problem or its seriousness will be reduced (Rosenstock, 1974).  
iv) Perceived barrier is concerned with an individual’s assessment of obstacles to 
health behaviour. In this construct, HBM proposes that barriers may prevent engagement in 
health promoting behaviour even if the individual perceives that the particular health problem 
poses a threat and has confidence that the threat will be effectively reduced by that particular 
behaviour (Janz & Marshall, 1984; Glanz et al. 2008). 
Although it is the most widely used theory used to investigate the reasons for people’s 
failure to undertake measures that are health preventative, HBM has been criticized for the limited 
predictive capacity of its existing variables and small effect size of the variables (Orji, Vassileva, 
& Mandryk, 2012). Despite this criticism, many studies have used HBM to explain health 
behaviour. Psychologists have used HBM to provide a better understanding of the reasons why 
tuberculosis screening programs have experienced a widespread failure and to explain many other 
aspects of health behaviour such responses of patients to disease symptoms, people’s reasons for 
complying with medical regimens, lifestyle related behaviours such as sexual risk behaviour and 
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chronic illness (Janz & Marshall, 1984; Glanz, 2008). For example Naghashpour, Shakerinejad, 
Lourizadeh, Hajinajaf and Jarvandi (2014) examined how an education program on nutrition has 
effect on female students’ knowledge, attitudes and practices (KAP) of dietary calcium. Another 
study evaluated how community-based health education programmes affect high school students’ 
prevention of injury (Zhi-Juan, Yue & Shu-Mei, 2014). Other studies namely Straub and Leahy 
(2014) as well as Zhang, Dalal and Wang (2013) have examined pro-environmental behaviour and 
injury related risk behaviour using HBM.  
Workagegn, Kiros and Abebe (2015) used two HBM constructs to find out what predicts 
utilization of HIV-test by ANC attendees. In this study, the authors found that there was a negative 
association between HIV-test utilization for PMTCT and negative or low perceived net benefit. 
Similarly, the relationship between acceptance of HIV tests, receiving results by mothers and belief 
in susceptibility to vertical transmission of HIV to infants was explained using the perceived 
susceptibility construct of HBM. Perceived benefits in the context of PMTCT is the belief by 
mothers that and the knowledge that PMTCT interventions have the benefits of effectively 
preventing HIV transmission to their babies (Igumbor, Pengpid & Obi, 2006). This study will use 
HBM to provide a useful basis for an enquiry into the factors influencing PMTCT service 
utilization by exploring whether a perception of seriousness, susceptibility, benefit or barrier are 
among the reasons why women fail to use PMTCT services. 
3.3 Social Support Theory 
Hobfoll and Stokes (1988) as cited in Goodwin, Cost and Adonu (2004), defined social support as 
“social interactions or relationships that provide individuals with actual assistance or with a feeling 
of attachment to a person or group that is perceived as loving or caring”. Two types of social 
support have been recognized in the literature; perceived and actual support. The support that is 
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received by an individual either by saying or giving something to the individual is termed actual 
support while perceived support is an individual’s belief that there is available support (Goodwin 
et al., 2004). 
 It is also widely acknowledged that perceived support predicts positive outcomes more 
often than actual support. As such lack of perceived support means low service uptake and 
utilization. For example, Uchino (1999) explained social support in terms of how perceived and 
received support are potentially linked with disease end points. One of his propositions is that 
positive psychosocial profiles are developed by family environments that are positive from early 
years. As such it is predicted that there is an association between parental support or less conflict 
with healthy behavioural choices and adherence to medical regimens.   
However, social support theory has its drawback. It is a model that is characterized by 
reciprocity and quantifies nurturance offered to someone as if a value can be affixed to it on some 
level when in reality, a value cannot be easily affixed to the gain achieved in assisting someone 
cared for (Shumaker & Brownell, 1984). Despite its drawback, many studies have linked social 
support to health outcomes. For example, Anderson, Winett and Wojcik (2007) found that higher 
social support levels were associated with higher self-efficacy to choose and prepare the most 
nutritional foods. Through support from friends and family, they obtained information about health 
eating and developed confidence that enabled them decide on healthy as opposed to unhealthy 
foods.  
The idea of perceived support is also applicable in utilization and adherence to PMTCT 
services. Results from a study conducted by Busza et al. (2012) found that although pregnant 
women may be concerned about their status, lack of motivation or self-efficacy may prevent them 
from accepting testing especially when the logistical arrangement involved is complicated when 
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they have to provide an explanation for their absence. Also, other studies have shown that male 
partner involvement in HIV testing and antenatal care means a statistically higher acceptance of 
ARV prophylaxis by their women, higher health facility delivery and attendance of follow-up 
visits (Busza et al., 2012).  Based on this proposition, this study assumes that the support available 
to an individual is associated with the ability to seek PMTCT services and utilize them. 
In order to identify the level of PMTCT service knowledge and awareness in Ibadan 
Nigeria, Arulogun, Adewole, Olayinka-Alli and Adesina (2007) conducted 20 individual in-depth 
interviews with household heads, religious and community based leaders. Knowledge of MTCT 
and PMTCT was low and community sensitization was low and health care facilities were 
inadequate. These findings are indicative of little or non-existence of social support mechanisms 
for PMTCT users. Hill et al. (2015) explored the effects of pregnancy and HIV status disclosure 
by adolescent women in an urban clinic located in Umlazi, South Africaon the relationships they 
have with members of their family and sexual partners while paying attention changes in support 
in the entire time period. In-depth interviews that were semi-structured with 15 HIV-positive and 
HIV-negative pregnant adolescents or those at the 18 month post-partum stage revealed that 
closeness with partners during pregnancy was heightened. A few women reported being in close 
relationships with their partners at postpartum and the support they experienced did not differ 
based on their HIV status. It is argued that perception of low social support from the general 
community will impact PMTCT service uptake and adherence to treatment negatively (Kagee 
2008; Perez et al., 2004). Results from studies linking social support and PMTCT utilization or 
adherence have proved this relationship.  
Data collected from Ditrame Plus project combined with interviews involving couples and 
women was used to analyze how decisions concerning the practices of infant feeding options for 
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HIV prevention are constructed (Traore´ et al., 2009).  It was found that knowing that their wives 
are HIV positive and being involved in program for PMTCT, men are more likely to actively play 
a role in applying the advice provided. They found that when men know their wife is HIV positive 
and are involved in the PMTCT project, they play an active role in applying the advice received. 
However, support from spouse is not always needed by women before undertaking preventative 
behavior.  
Another study was conducted by Psaros, et al. (2014). Interviews completed assessed 
depression, stigma, social support and structural barriers to PMTCT among 167 women infected 
with HIV who were enrolled in PMTCT at about 28 weeks of pregnancy. Lower adherence scores 
were found among participants whose depressive symptoms were elevated. Adherence was not 
predicted by income or the amount of time taken to reach the clinic thus, there was no basis for 
examining its moderation with social support. Social support was a significant predictor of 
depression and people who had lower score of social support had elevated depressive symptoms. 
Similarly, there is a significant association between stigma score and social support score. 
Another study conducted in Jos, Northern Nigeria by Sagay et al. (2006), explored 
problems relating to HIV status disclosure by sero-positive mothers to their partners in a PMTCT 
program. 570 mothers were selected from the PMTCT program and administered questionnaires 
that were previously field-tested. It was found that out of 560 participants, 500 or 89 percent of 
the women revealed to their partners that they were HIV positive. Of these, 199 or 39.6 per cent 
were assisted by health workers while 298 or 59.4 per cent accomplished it unassisted. After 
revealing their HIV status, 430 or 86.9 per cent of the partners reacted in a supportive manner, 5.7 
per cent reacted indifferently, 67 per cent quarreled and abused their partners while 1.0 per cent 
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reacted violently. Since partner support was high in this study, it is expected that utilization and 
adherence to PMTCT services will be high as found in aforementioned studies. 
Nassali et al. (2009) interviewed HIV-positive mothers at postpartum with the aim of 
determining adherence to PMTCT at the postpartum stage based on the percentage of mothers who  
attended follow-up appointments after eight weeks postpartum. Focus group discussions were also 
used for the assessment of influencing factors of adherence to PMTCT at postpartum. One of their 
findings is that the most important factors motivating mothers to adhere to PMTCT is the 
availability of social support from their partners. 
3.4 Conclusion 
In summary, health belief model assumes that patients’ decisions to utilize health services 
or adhere to medication is based on their beliefs about how serious the disease is, or how 
susceptible they are to complications, the benefits they derive from utilization and adherence as 
well as the potential barriers they might face. Most of the studies reviewed have revealed that a 
positive relationship between health belief and utilization means that high perceived seriousness, 
susceptibility, benefit and barriers will result in high utilization and adherence, vice versa.. It 
therefore follows in this study that WLWHA who partake in PMTCT services because of their 
health or the health of their babies are assumed to have high perceived benefit or susceptibility 
respectively. This implies the need to constantly engage with WLWHA to provide them with 
knowledge and reminders that will shape their beliefs about PMTCT utilization and adherence.   
 
 
The social support theory assumes that perceived support is a strong determinant of health 
service uptake or utilization and adherence. Most of the literature on social support found that high 
perceived support is associated with high service uptake and vice versa thus indicating a positive 
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relationship between social support and health service utilization. This link provides a useful basis 
for the use of hospital coordinated support from mentor mothers or peer mentoring for 
improvement of utilization of PMTCT services. It therefore follows in this study that WLWHA 
who were accompanied by their partners or family members during antenatal care or received some 
form of financial or other support during their pregnancy are assumed to have high perceived 
support. 
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CHAPTER 4 
METHODOLOGY 
In this chapter, the research design, data collection approach, population and sampling techniques, 
description of study site and scope of the study, data analysis, ethical considerations as well as 
validity measures were addressed. 
4.1 Study Site 
The study was conducted in Rivers State Nigeria. Rivers State is located in the South-South 
Geographical Zone in Nigeria and it is administratively divided into 23 local government areas as 
shown in figure 2.  
Figure 2: Map of Rivers State, Nigeria 
 
 
 
 
 
 
 
 
 
Source: Rivers State Ministry of Health, (2013) 
Based on the population census carried out in 2006,there was a total population of 2,673,026 males 
and 2,525,690 females in Rivers State which grew to about 6,429,596 people at the end of 2012 
(Rivers State Ministry of Health, 2013). The most recent estimates show that Rivers state had 
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1,414,511 women of reproductive age (WRA) and the 321,480 pregnant women (Rivers State 
Ministry of Health, 2013).   
Rivers state was chosen for this study because of its HIV prevalence rate of 3.8 per cent 
making it one of the highest in Nigeria according to the (Federal Ministry of Health, 2016). About 
19,289 pregnant women were HIV positive out of the estimated 321,480 pregnant women residing 
in Rivers State (Rivers State Ministry of Health, 2013) meaning that prevalence rate among 
pregnant women in the state is 6%. 
4.2 Research Design 
This study used qualitative design to provide detailed understanding of PMTCT from the point of 
view of women living with HIV/AIDS as well as the factors influencing its utilization instead of 
providing an analysis of statistical results (Soiferman, 2010).Each stage of a qualitative research 
design is like a journey that builds on past experiences (Richards, 2005). According to Creswell 
(1994), qualitative design is more concerned with processes rather than outcomes. In this study, 
the qualitative research process is inductive which involves collection of data from the field and 
generating meaning from it (Crotty, 1998). The qualitative method relevant to this study is 
phenomenology. This was chosen because it is a qualitative approach that can interpret the existing 
practices of women living with HIV/AIDS regarding their use and adherence to PMTCT services. 
“In qualitative research, the epistemological assumption, philosophical basis, nature and 
limits of human knowledge is that each individual has a different view of the world and thus it is 
difficult to generalize findings and draw inferences simply on the basis of quantitative research” 
(Soiferman, 2010, p. 16). This epistemological assumption is referred to as social constructivism 
and is relevant to this study because it can easily be applicable in the socio-cultural world. The 
assumption guiding social constructivism states that “the social world is without meaning prior to 
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one’s experience of it and truth or meaning comes into existence in and out of ones engagement 
with the realities of one’s world” (Crotty, 1998, p.8). Constructivism in this study will be based 
on empirical research that seeks to gain understanding of the situation as it is through knowledge 
derived from experiences of WLWHA. This is why open-ended questions are used by researchers 
in order for participants to share their experiences (Crotty 1998). The ontological stand-point of 
the qualitative researcher in this study mainly reflects inequality with respect to gender particularly 
how women’s poor economic backgrounds, their inferior roles in the family, radical religious and 
cultural beliefs and how these affect their use of PMTCT services in relation to more economically 
advantaged and more culturally liberal women. 
4.3 Population and Sampling Techniques 
413 health facilities are involved in provision of ANC in Rivers State. Of these, 66 health facilities 
of make provision for ARVs as part of PMTCT (Rivers State Ministry of Health, 2013). The 
population in this study comprises three categories of participants in the Nigerian health system: 
Stakeholders (Health care staff such as doctors, PMTCT nurses and midwives); representatives 
from HIV/AIDS support groups and Women Living with HIV (WLWH) all of whom are from 
varied socio-economic backgrounds and with a broad socio-demographic mix. 
This study used purposive sampling technique to select participants from the population.  
Purposive sampling is defined as a sampling method in which participants are chosen based on 
particular features of the study (Strydom & Delport, 2002). Purposive sampling allows the 
researcher to select relevant, rich cases which provide in-depth information (Patton, 2002). This 
method was chosen in order to obtain responses that are relevant to PMTCT service utilization and 
adherence. However, purposive sampling is prone to bias because it is created based on the 
judgement of the researcher (Sharma, 2017). This affected the procedure used in choosing health 
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care providers because the researcher expected the sample to consist of only obstetrics and 
gynaecologists when in fact, surgeons, general physicians and even paediatricians would have 
sufficient knowledge of PMTCT guidelines. Despite its limitations, purposive sampling was 
chosen because not all of the health providers are trained on compliance with PMTCT guidelines 
and not all HIV positive women have been pregnant in the past. Therefore to reduce the bias caused 
by the use of purposive sampling, the researcher established a selection criteria which allowed the 
selection of general physicians, obstetrics and gynaecologists and surgeons who are better trained 
on PMTCT guidelines than other health professionals. Ten health care providers from a 
government owned hospital in a sub-urban area and ten representatives from support groups were 
selected from the Network of People Living with HIV and AIDS in Nigeria (NEPWHAN). This 
sample size includes five representatives each from two support groups and ten PMTCT health 
providers from the hospital selected for the study. Similarly, purposive sampling was used to select 
twenty HIV positive women from the two support groups. The sample size consists of ten HIV 
positive women from each of the two support groups selected in Rivers State. These respondents 
were selected based on the following inclusion and exclusion criteria: 
 
Inclusion and Exclusion Criteria 
Key informants in this study were selected based on their knowledge of PMTCT services being 
investigated. They need to be the most experienced health care providers of pregnant WLWHA. 
The Nigerian Ministry of Health (2010) requires that HIV positive pregnant women should be 
provided with ARVs either as prophylaxis of therapy during pregnancy, labor and at postpartum 
during breastfeeding. Therefore only WLWHA who have been pregnant in the last four years were 
selected in order to obtain information on their immediate postpartum experiences and outcomes. 
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Women who are currently pregnant were excluded because they can only provide responses related 
to their antenatal care experience thus neglecting labor and infant feeding experiences. 
 
Recruitment of Key Informants 
After obtaining ethical clearance and permission to conduct research at selected PMTCT sites, the 
researcher met with the clinic managers to collect a list of nurses or midwives, their years of 
experience and their work schedules to find out their availability and make appointment with them. 
In each of the PMTCT sites selected for this study, PMTCT nurses or midwives or doctors were 
identified and approached to enquire about their willingness to partake in the study. The same 
procedure was carried out to recruit 10 members from HIV/AIDS support groups. 
 
Recruitment of Women Living with HIV/AIDS 
After interviewing key informants in HIV/AIDS support groups, each key informant was asked 
about the characteristics of their members to establish which of them has been pregnant in the last 
one year and twenty women were identified and their group meeting days. The researcher then 
attended a support group meeting to meet the women and enquire about their willingness to partake 
in the study and their preferred language. Once they consented to participate in the s tudy, an 
appointment was made with them to meet before or after the support group meeting or in a private 
room with only the researcher and a field assistant who speaks the language of the participant.  
 
4.4 Data Collection Approach 
Given the nature of the issue under inquiry, two semi-structured in-depth interview sheets were 
administered to both key informants and HIV positive women selected from support groups and 
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PMTCT nurses or midwives and doctors in hospitals. A semi-structured in-depth interview 
involves the use of an interview guide covering a list of questions usually in a particular order but 
the interviewer is able to stray from the guide when it is necessary (Cohen, 2006). These involve 
verbal, open and direct questions to obtain participants’ views. In-depth interview of the 
participants was chosen because it holds more promise in yielding valuable information through 
interaction with participants and gives room for asking other questions that arise during the 
interviews. It also allows the researcher to ask for clarification on participants’ opinions and to 
identify new ways of understanding and comparing the different viewpoints on PMTCT utilization 
challenges. According to Boyce and Naele (2006), in-depth interviews have the advantage of 
providing more detailed information than what is available through survey data.  
Given the diversities in language and culture in Rivers State, some of the women not have 
knowledge of English language. It is known that most of the people in Rivers State speak or hear 
English or Pidgin languages. Although the native languages in Rivers State are Ikwere, Ijaw and 
23 others, many people can speak or understand Igbo language in the state. Therefore translation 
of interviews was necessary from English language to the native Igbo language and Pidgeon 
spoken by indigenes of Rivers State. In doing this, the research adopted the back translation 
method which involves using one translator in translating a questionnaire into a target language 
and then using an independent translator who is blinded to the original questionnaire to translate 
it back into the source language (Sperber, 2004). This method was chosen because it is more likely 
to ensure that the certain informal phrases or slangs and jargon, or idiomatic expressions and terms 
which can be emotionally evocative are not lost in the translation process. The following steps 
were taken in back translation of the study tools (Sperber, 2004): 
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i. The English version of the interview sheet was translated by trained researchers who 
are proficient in igbo language and pidgin. 
ii. The translated igbo and pidgin versions of the interview sheets were then translated 
back to English by another trained researcher who is also proficient in igbo and pidgin 
languages. 
iii. Finally the translated copies were compared to test for accuracy and to ensure that the 
original interview sheet has not been distorted. 
The interviews took place in participants’ preferred language with the support of a field assistant 
who was trained and provided with knowledge about the research, its aims and objectives, as well 
as ethical issues surrounding the interview process. The interview sheets were pre-tested in order 
to assess and identify areas that need to be adjusted. The interview sheets were pretested on a 
pharmacist, an NGO representative and a WLWHA who were purposively selected in Abuja. The 
pre-test participants were given informed consent forms and the WLWHA was recruited by the 
NGO representative. After pre-testing, some questions appeared repetitive and were therefore 
merged. 
A pilot study was done in Abuja, the capital city in Nigeria. Conducting a pilot study was 
necessary because it has the advantage of giving advance warning about the possibility of the main 
research failing. It could also pinpoint stages where parts of the research protocol may be skipped 
or adjusted, or whether there is a problem with appropriateness of the proposed methods or 
instruments or if it is too complicated (De Vaus, 1993). The same interview sheet was administered 
to key informants and WLWHA. The interview sheet typically contained demographic information 
about the participant such as participant ID which was numbered to ensure anonymity, age, marital 
status, occupation and level of education. This was followed by open-ended questions regarding 
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the seven steps in the PMTCT continuum namely; antenatal care attendance, adherence to 
voluntary counselling and testing, adherence to ARV medication, labour and delivery practices, 
infant feeding practice, infant follow up at postpartum and infant adherence to ARV medication. 
The research used a tape recorder with the permission of participants and the data collected was 
merely about participants’ perspectives regarding the research question on barriers and challenges 
to PMTCT service utilization. Interview sheets that were used for both key informants and 
WLWHA are attached in the appendix section. 
Table 2: Summary of Participants 
Doctors/Nurses/Midwives 10 
NGO representatives 10 
Women Living with HIV/AIDS (WLWHA) 20 
Total Number of Participants Reached 40 
 
4.5 Data Management and Analysis 
Data collected through in-depth interviews were inserted into Nvivo qualitative data analysis 
software and analyzed by means of content analysis as described by Tesch as cited in Creswell 
(1994). In this approach, the researcher looked for patterns and themes in conversations. The 
themes were then grouped by their relevance to the research question and sub-questions. Tesch as 
cited in Creswell (1994) provides a description of systematic theme analysis where the researcher 
uses a step by step method to objectively and systematically organize data. Information obtained 
from the key informant interviews were also analyzed using Tesch’s steps which involve 
identification of themes and sub-themes by repeatedly reading through, coding and categorizing 
the interview sources. In other words, each sub-question was reviewed to find consistencies and 
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differences among interview data and relevant theories. Eight steps involved in Tesch’s data 
analysis procedure were adopted. These include: 
1. All transcriptions were read carefully while noting any ideas that the researcher thought 
were relevant. 
2. One interview was selected, read and the meaning of all the relevant information was 
extracted and written out. 
3. The researcher then went through the transcripts and grouped all similar topics into 
columns which were labelled as: Major topics, unique topics and leftovers. 
4. Next the researcher abbreviated the topics into codes and wrote them next to the appropriate 
segment of each test. Then the data was organized and observed carefully to check for 
emergence of new categories. 
5. The topics were fully described using the most suitable wordings followed by conversion 
of the words into categories in order to group similar topics together and therefore shorten 
the total list of categories. The groupings were indicated by drawing lines between the 
categories showing how the categories are interrelated. 
6. Each category was then given a final abbreviation followed by an alphabetical arrangement 
of the codes. 
7. Next was the gathering of all the data material that belonged to each category into a single 
file then performing a preliminary analysis. 
8. Finally, the data was recoded where the researcher though it was necessary” (De Vos, 2002, 
p. 340).  
This method of analysis was selected to enable results derived from interviews to be used in 
confirming theories relating to how gendered experiences of women inhibit their use of PMTCT 
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services in Nigeria. Challenges facing women in obtaining ARV drugs, HIV/AIDS counseling and 
formula milk for infants were identified from the interviews. 
Using Nvivo qualitative data analysis software, all interviews were examined by reading 
through and making notes. Thereafter, all aspects of PMTCT that were relevant to this research 
were coded and assigned to categories/themes. The categories were then assigned to relevant 
sentences and paragraphs in order to describe all aspects of the interviews. A summary of coding 
and responses is included in Appendix 4. Properties of the codes were merged with key concepts 
then transformed into key variables (namely social support and health belief model) which are the 
main theories of interest in the study. Due to extensive pre-analysis of various literature sources as 
well as the PMTCT cascade which were discussed in chapters 2 and 3 of this study, a start list of 
categories was drawn up and a categorization matrix was developed as described by Elo & Kyngas 
(2008). Prior knowledge and assumptions from the literature review in chapter two served as a 
basis for pre-existing nodes that were compared with the responses gathered. The researcher then 
looked for similarities and differences between the nodes and organized them into a meaningful 
description of key themes and categories. Finally, the descriptive themes and their associated data 
were examined in light of the research questions, theories, assumptions and literature sources in 
order to make inferences on factors influencing PMTCT utilization and adherence. Table 2 
summarises the criteria that was used in coding some of the responses based on a pre-determined 
set of themes. 
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Table 2: Themes 
Name Description 
Access to CD4 count 
Services 
CD4 count experience, Follow up counts, support, 
Antenatal Care 
Attendance (ANC) 
Stage of first ANC visit, how often WLWHA attended ANC, 
attitude to follow up visits and support received from partners, 
friends and relatives 
Baby testing and treatment Time of testing, results, follow up test, status of other children, 
challenges with taking ARV, Support 
Effect of Stigma on use 
and adherence to PMTCT 
services 
reasons for experiencing or not experiencing stigma and 
discrimination 
HIV Testing Time of first test, knowledge of HIV status, support received, 
HIV status disclosure 
Immediate Postpartum 
experiences of WLWHA 
Provision of ARV to mother and baby, support, challenges, 
follow up visits with baby 
Infant feeding experiences 
of WLWHA 
Reasons for choice of infant feeding, length of time baby was 
exclusively breast or formula fed, reasons for stopping the mode 
of feeding, constraints to chosen infant feeding 
Key informant 
recommendations 
What can be done to improve ANC attendance and what is the 
NGO/hospital doing to improve it? 
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Transcripts of Interviews and responses to open ended questionnaires were analysed using the 
process described by Tesch, (1990). Responses from both WLWHA and key informants were 
closely examined to create labels that summarize their experience of PMTCT service utilization 
and adherence as described in Table 3. 
 
Table 3: Framework for Analysis 
Main Themes Categories Subcategories 
Reasons for PMTCT service 
use and adherence 
Importance of having a 
healthy mother and a 
negative baby  
Lives of mother and unborn 
child 
HIV Testing Knowledge and disclosure of 
HIV status 
Testing late 
Non-disclosure 
CD4 count experiences/ 
Follow up counts 
Quality of hospital services Unavailability of service at 
hospitals 
Challenges of HAART use 
and adherence 
Institutional, cultural and 
religious factors 
Side effects of drugs, 
administrative bottlenecks, 
shortage of drugs supply/stock 
outs, religious factors, indirect 
costs, cultural factors 
Labour experiences of 
WLWHA 
Skilled birth attendance TBA attendance, Un-booked 
cases. Reluctance, un-
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seriousness, hiding, Finance. 
Too late to go to the hospital 
Immediate postpartum 
experience of WLWHA 
Failure to attend follow up 
visits with baby 
Side effects of ARV 
medication, economic 
hardship, lack of information 
about prophylaxis for baby 
Baby testing/follow up tests Inaccurate information No follow up tests for babies 
Infant feeding practices of 
WLWHA 
Acceptance and health of 
nursing mothers 
Confusion about infant feeding 
choices, poor lactation, 
inability to cope with EB, 
working mothers, family 
pressures, ignorance, poor 
information about baby’s 
nutrition, latching problems, 
Acceptance by babies, fear of 
having cuts 
Family and Community 
Support 
Male partner and community 
/ Family involvement 
 
 
 
Lack of financial or moral 
support from partners, 
relatives and friends 
Effects of stigma and 
discrimination 
Non-disclosure of HIV status Religious sentiments and 
ignorance 
75 
 
Discrimination by family or 
community 
Use of family planning 
services 
Prevention of unintended 
pregnancies 
Family size, financial reasons, 
prevent transmission, spacing 
pregnancies 
4.6 Data Verification Procedures 
The process whereby information is checked and confirmed, making sure and being certain is 
called verification. By verifying, the researcher is ensuring that there is reliability and validity as 
well as rigor in the study (Morse, Barrett, Mayan, Olson & Spiers, 2002).   
Transferability. This is the process of representing different perspectives by establishment 
of similarities and differences across accounts (Morse et al., 2002 & Slevin, 2002). To achieve 
this, the findings in this research were supported and compared with verbatim accounts of selected 
participants which are thought by the researcher to be rich and thick. 
Confirmability. This is when personal biases that may have an influence on the findings 
are accounted for (Morse et al., 2002). The researcher therefore recorded all the data accurately 
and provided a clear decision trail as well as ensured consistent and transparent interpretations. 
Credibility. Krefting (1991) mentions peer review and member checking as ways of 
ensuring credibility in research. The researcher therefore conducted member checking by 
contacting the interview participants to clarify any disputed issues on the data collected. This 
ensured an honest account of PMTCT service utilization. Peer review was done by discussing the 
research process and findings with experts in qualitative research methods including the 
researcher’s supervisor who has experience in PMTCT research. 
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Dependability. To ensure dependability, data types and methods are mixed in the form of 
triangulation as described by Olsen (2004) in order to validate claims that might emerge from a 
first pilot study. As such data from the information gathered from key informants was assessed 
against interview data with WLWHA in this study to ensure diverse viewpoints, higher predictive 
validity and reliability as described by Hunter and Hunter (1984) as cited in Olsen (2004). 
 
4.7 Ethical Considerations 
In order to conduct research on human subjects, certain guidelines need to be followed 
regarding participants’ rights as stipulated by the national commission for the protection of human 
subjects of biomedical and behavioral research 1979. Therefore the standards of research 
prescribed by this commission in the Belmont report was adhered to by the researcher. The ethical 
considerations that were addressed include: human participants’ protection, informed consent, do 
no harm and the right to privacy, voluntary participation, anonymity and confidentiality.  
Human participants’ protection. Ethical approval was obtained from the University of 
Cape Town’s research ethics committee and the Federal Ministry of health in Nigeria. Permission 
was also sought from the Management of hospitals and support groups in order to conduct key 
informant interviews.  
Informed consent. The participants of the research must know about their entitlement to 
decline at any stage of the interview for any purpose and to re-claim any data provided by them. 
Also the Social Research Association provides that no information that has the possibility of 
affecting the willingness of participants to partake in the study should be withheld. This research 
therefore obtained written consent from participants which is accompanied by the researcher’s 
proposal and contains an explanation of the purpose of the research and what the process is, any 
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limitations to participating in the research and information regarding the possibility of risks they 
may experience. 
Anonymity and confidentiality. The researcher guaranteed participants that no attempt is 
made to identify them in any form and the data gathered including tape recordings will be kept 
safe with restricted access. Ensuring anonymity means that the data will not be linked in any form 
to the participants’ identities (Social Research Association 2003). To ensure this, only the 
researcher and participant were present at the interview room. No data regarding personal details 
of participants was required by the researcher. Names of NGOs were changed into codes as soon 
as the data was organized. Also, any audio tapes used were preserved in a safe and well protected 
place, inaccessible to anyone but the researcher and supervisor. The tapes will be erased after one 
year.   
Protection from harm and the right to privacy. The interview was conducted in a private 
place where no-one else will listen to the conversation. In order to further protect participants’ 
rights to privacy, the researcher focused only on the questions relevant to the research objectives. 
Voluntary participation. Participants were informed that partaking in the study was 
absolutely voluntary and participants were assured that should they decide not to participate, their 
decision will not affect their existing or subsequent relationship with the supervisor or service 
provider in any way. The researcher informed participants that if for any reason, they do not want 
to continue the interview, the interview will be stopped, no questions asked and that they possess 
the right to stop or terminate the interview at any stage without facing any consequences.  
4.8 Limitations of the Study 
The researcher's presence during interview, which is unavoidable in qualitative research, may have 
affected the reliability of responses of PMTCT care givers who may feel the need to provide 
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socially desirable answers. The women living with HIV/AIDS were reluctant to divulge 
information especially when they became emotional. This affected the adequacy of their responses 
in addressing the research questions in the study. Another limitation of the study is the reluctance 
of key informants to accept recording of the interviews due to heavy work load in health facilities. 
As a result, they were allowed to fill in the interview sheets in the presence of the researcher. 
Although open-ended questions were asked, some key informants provided responses either in the 
affirmative or negative without responding to the probe questions. To curtail the effects of this, 
the researcher asked additional probe questions to explain the rationale behind the questions. 
However, this was not possible for all key informants because some inexperienced key informants 
did not have enough information about PMTCT while others simply did not have time to respond 
adequately to all questions. 
Given the nature of the topic HIV/AIDS, a more rigorous methodology would have been 
to interview PMTCT mothers and health care providers from resource poor settings but this was 
outside of the scope of this research. The extensive ethics procedure for a highly sensitive topic 
such as HIV/AIDS led to delays in obtaining the necessary permissions to conduct interviews in 
state owned clinics. As such, only one Federal Government owned and one private hospital were 
selected. Although the findings are broadly representative of prevailing PMTCT practices in 
Nigeria, caution should be exercised in generalizing findings to other geographical settings. The 
research found that some WLWHA mixed breast feeding with other liquids because the mother’s 
milk was not enough and baby was not satisfied. However, the researcher expected to find more 
of cultural practices regarding exclusive breast feeding such as the need give traditional medicines 
to their babies. 
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4.9 Reflexivity 
The researcher was drawn to the topic on PMTCT because a woman known to the researcher for 
many years found out she was HIV positive only two weeks before she died. If she had received 
antenatal care during pregnancy, she could have known her HIV status. Perhaps her baby died 
because of MTCT. This prompted the researcher to find out why women fail to use PMTCT 
services. Furthermore, the researcher shares similar gender experiences with participants coming 
from a culture where women are always regarded as inferior compared to their male counterparts 
and the health needs of women are often neglected. These similarities enabled the researcher to 
approach participants from an objective point of view while sharing experiences and being 
empathetic in interactions with them. 
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CHAPTER 5 
PRESENTATION AND DISCUSSION OF FINDINGS 
This chapter presents findings from in-depth interviews conducted with 20 WLWHA, 10 NGO 
representatives and 10 doctors on their experiences and perceptions of the use and adherence to 
PMTCT services in Rivers State. The chapter begins with a description of demographic profile of 
respondents. It follows with an in-depth presentation of major findings of the research. Drawing 
on the theoretical assumptions offered by social support theory and health belief model, the study 
investigates the extent to which WLWHA’s decision to use and adhere to PMTCT services is 
shaped by these variables. The broad themes that emerged were organized based on the Nigerian 
PMTCT cascade/guidelines. 
5.1 Socio-demographic Profile of Respondents 
As shown on table 4, participants from WLWHA comprise 6 women from Rivers State, 5 women 
from Imo, 3 from Abia State, 2 from Anambra State and others from Ebonyi State, Delta, Niger 
and Benue States. This means that most of the respondents came from the South South and South 
Eastern parts of Nigeria, the regions with the highest HIV prevalence as discussed in chapter 1 of 
the study. Over half (11) of the respondents speak Igbo language, 3 speak Ikwerre while others 
spoke either Kalabani, Ogoni, Urhobo or Odoma language but all respondents had fair or average 
command of the English language thus they did not require a translator. It is also evident from 
table 1 that all the respondents were married except one who indicated that she was a widow. The 
maximum age of WLWHA interviewed was 46 while the minimum was 30 years old although 
most of the women were in their 30s. The average age of WLWHA was 36 years. Since 95 per 
cent of the WLWHA were married the researcher therefore expected to find that there is optimum 
support received by WLWHA from partners and relatives. 
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Table 4: Socio-demographic Profile of Women Living with HIV/AIDS (WLWHA) 
Participant 
Category 
Age State Ethnic Group Marital Status 
WLWHA 1 33 Abia Igbo Married 
WLWHA 2 36 Rivers Ikwerre Married 
WLWHA 3 38 Rivers Ikwerre Married 
WLWHA 4 35 Imo Igbo Married 
WLWHA 5 41 Imo Igbo Married 
WLWHA 6 34 Rivers Kalabani Single 
WLWHA 7 46 Rivers Ikwerre Married 
WLWHA 8 44 Ebonyi Igbo Married 
WLWHA 9 37 Abia Igbo Married 
WLWHA 10 37 Abia Igbo Married 
WLWHA 11 30 Rivers Ogoni Married 
WLWHA 12 30 Rivers Christianity Married 
WLWHA 13 30 Niger Edo Married 
WLWHA 14 34 Anambra  Igbo Married 
WLWHA 15 34 Delta Urhobo Married 
WLWHA 16 33 Anambra Igbo Married 
WLWHA 17 34 Imo Igbo Married 
WLWHA 18 36 Benue Idoma Married 
WLWHA 19 40 Imo Igbo Married 
WLWHA 20 38 Imo Igbo Married 
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Of the 21 key informants interviewed, majority (17) were from Rivers State. Majority of them 
spoke either Ijaw (7) or Igbo (6) languages while the remaining 7 key informants spoke either 
Ogoni, Ikwerre, Tsekiri or Efik languages. Almost all the key informants had bachelor’s degree 
with only 1 Master’s degree holder, 1 Diploma and 1 respondent with no degree at all.  This 
indicates that the literacy level in Rivers State is quite high. In addition, half of the respondents or 
all the health care providers interviewed were either medical doctors or Obstetrics and 
gynecologists while the NGO representatives or half of the key informants were either counsellors 
nurses, social workers, data entry clerk or volunteers.  
This profile indicates that there is a high caliber of health care providers working at the 
health facilities meaning that WLWHA should be receiving high quality information on PMTCT 
and survival strategies for their babies. The average age of key informants was 35 years. Of the 21 
key informants, only 6 females were interviewed with only one female doctor out of 11 indicating 
that either males were more willing to be interviewed than their female counterparts or there were 
more males in the sample selected.  
Table 5: Socio-demographic Profile of Key Informants  
Participant 
Category 
Age State/ Ethnic 
Group 
Education Occupation 
Dr 1 35 Rivers/ Ijaw MBBS Obs & Gynae 
Dr 2 41 Rivers/ Urhobo MBBS, Consultant MD, Obs & Gynae 
Dr 3 28 Rivers/Igbo MBBS, MWACS Obs & G, Senior Registrar 
Dr 4 30 Rivers/ Ijaw MBBS MD, Gynae 
Dr 5 32 Rivers/ Igbo MBBS MD 
Dr 6 37 Rivers/ Ijaw MBBS MD 
Dr 7 39 Rivers/ Ijaw MPH, MBBS MD 
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Dr 8 30 Rivers/ Ijaw MBBS MD 
Dr 9 34 Rivers/ Ogoni MBBS Medical practitioner 
Dr 10 33 Rivers/ Igbo MBBS O & G Registrar 
Dr 11 34 Rivers/ Ogoni MBBS, MSc Public health physician 
NGO 1 40 Ebonyi/Igbo  M & E officer 
NGO 2 44 Rivers/ Ikwere BSc Social worker 
NGO 3 25 Abia/Igbo BSc NGO representative 
NGO 4 49 Delta/ Itsekiri BSc Graduate volunteer 
NGO 5 37 Rivers/ Efik BSc Counsellor 
NGO 6 28 Rivers/Igbo BSc Nurse 
NGO 7 35 Imo/Igbo BSc Volunteer 
NGO 8 22 Rivers/ Efik Diploma Data entry clerk 
NGO 9 45 Rivers/Ijaw SSCE Social worker 
NGO 10 28 Rivers/ Ogoni BA Data entry clerk 
 
5.2 Reasons for PMTCT Service Use and Adherence 
Most of the WLWHA attended ANC at a health facility from 12 weeks according to the 
instructions provided at the health facility. All participants responded that they attended at least 4 
ANC visits and even more throughout their pregnancy mostly because it is expected to be a 
monthly routine visit. Contrary to the NACA (2014) PMTCT communication strategy that 
highlighted pregnant women’s low motivation to use PMTCT services this finding indicates high 
utilization among the WLWHA interviewed.  This may be due to the fact that most of the women 
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were informed of their HIV-positive status at the time of antenatal care and are therefore 
adequately linked with appropriate PMTCT services. 
Importance of Having a Healthy Mother and Negative Baby. 
When the theme reasons for utilization of PMTCT services and adherence was explored, most of 
the respondents noted that they attended all their antenatal care appointments. This was confirmed 
by key informants as evident in the following excerpt; Mothers occasionally miss their 
appointments but adherence is good (Public health physician, age 34). WLWHA unanimously 
stated that they used the services because they wanted to stay healthy and to have HIV negative 
babies; Yes. I attended because the life of my unborn child was very important to me (Mother of 2, 
age 33). Another WLWHA states; Yes. I followed all instruction given me because I wanted to live 
long (Mother of 2, age 33).This is supported by a third WLWHA who states that she adhered to 
PMTCT; To ensure that the baby is HIV negative (Mother of 5, age 36). These responses are 
indication that many women are aware of the health benefits of PMTCT and are ready to use and 
adhere to instructions of health care providers as far as possible.  
 
These findings are consistent with the assumptions of perceived susceptibility in the health 
belief model which assumes that when an individual has confidence that the susceptibility to the 
disease will be reduced (Rosenstock, 1974), they are more likely to engage in a healthy behaviour 
in this case, utilize PMTCT services. However, it was observed that the price of booking for 
antenatal care can hinder some women from attending ANC as noted by a key informant; the price 
of booking is a concern (M&E officer, age 40). This is especially a problem for WLWHA who 
attend private health facilities. According to the perceived benefit in health belief model as 
described by Glanz et al. (2008), this perceived barrier did not reduce the level of utilization or 
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adherence to PMTCT because of their assessment of the value or efficacy associated with PMTCT 
to their health and their babies’.  
5.3 HIV Testing 
Mofenson & Mclntyre (2000) stated that a woman cannot make informed choices about 
preventative interventions unless she knows her HIV status. All the WLWHA interviewed in this 
study accepted HIV counselling and testing services even though some WLWHA did the test 
before pregnancy and already knew their HIV status before the first ANC visit. 
Knowledge of HIV Status and Disclosure. 
Generally, HIV testing was accepted by WLWHA given that most hospitals practice provider 
initiated HIV testing with the opt-out approach to ensure that every patient who presents for ANC 
is tested. This is evident in the following statement made by a key informant; Women on ANC 
visits do not resist testing and WLWHA are compliant with their medications as they believe it will 
help the baby from contracting the disease (Gynaecologis/Obstetrician, age 41). Most of the 
WLWHA find out their HIV status at the first stage of ANC while a few find out even before 
getting pregnant. These categories of respondents utilized PMTCT services. Two respondents 
reported that they found out their status during their earlier pregnancies and did not benefit from 
PMTCT services at the time; 
 
I discovered I was HIV positive when I was pregnant with my second 
child. My husband was also tested and confirmed positive for the 
virus. We were, thereafter placed on drug therapy (Mother of 2, age 
33). 
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Another respondent states; 
No I never knew I was positive, No, I only did testing during second 
pregnancy (Mother of 2, age 28). 
A third woman only found out her HIV status after giving birth, making the risk of transmission 
to the baby very high. In these cases, their oldest children were therefore found to be positive thus 
indicating the importance of early knowledge of HIV status. As one of the WLWHA who 
discovered her HIV status late stated; my first was positive but the other two are negative (Mother 
of 3, age 34).  
 
Furthermore, most women reported that they disclosed their status to their partners even 
though the partners were barely seen with them at the hospitals as stated by a key informant. I have 
not seen their partners (Medical Practitioner, age 34). This statement is confirmed in the response 
of a WLWHA. No. the only time my partner accompanied me for a test was when we were about 
getting married (Mother of 5, age 36).  Others chose to disclose their results only to their partners 
to avoid stigma as evident in the following statement while another tested in church all of which 
can lead to non-adherence to PMTCT services. Yes. I disclosed it to my partner alone”. “I tested 
in church (Mother of 3, age 44). These statements indicate lack of support to WLWHA by their 
partners during pregnancy. Also those who did not disclose their HIV status to anyone other than 
their husbands may not have any source of support since no friends and family members 
understand their situation. This finding does not conform to the theory of social support which 
assumes that more support indicates more utilization. In this study, more utilization was associated 
with less support. For example, it contradicts the finding of the study conducted by Busza et al. 
(2012) which showed that male partner involvement in HIV testing and antenatal care means a 
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statistically higher acceptance of ARV prophylaxis by their women, higher health facility delivery 
and attendance of follow-up visits.   
 
Regarding baby testing, respondents were asked whether WLWHA tested their babies at 6 
weeks and at 18 weeks. Generally, their responses were positive mainly due to maternal interest 
and to check the health status of their babies. However, it was observed that after testing at 6 weeks 
and baby is negative, some women did not bother to return for the second test at 18 weeks with 
many responses like; No, just at birth (Mother of 2, age 33). Its been up to a year and some months 
(Mother of 2, age 28). With the babies who were tested and found positive, it is difficult to treat 
the babies especially when they are too young to understand their status. It is evident that there is 
a perceived barrier that is consistent with the health belief model based on the quote from a WLWH 
who states that; 
He keeps asking why he is the only one taking the drugs and I keep 
telling him that I want him to be healthier than others but I have not 
told him the truth about his condition. I intend to do that at some 
point in time (Mother of 3, age 34).  
 
5.4 CD4 count experiences/follow up counts 
Like ANC and HIV testing, CD4 count check and follow up were also well utilized by WLWHA 
although some challenges were discovered.  
Quality of Hospital Services. 
WLWHA recounted their CD4 count experiences. They expressed willingness to check their CD4 
count and follow up counts as evidenced by the following statement made by a WLWHA; 6 months 
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in order to know how im doing (Mother of 3, age 30). Another WLWHA states; Every six months 
to know if ART is working or not. I followed it as instructed (Mother of 3, age 34). These statements 
were confirmed by a key informant who stated that; It is generally accepted as most people wish 
to know their CD4 as an assessment of improvement or decline (Public health physician, age 34). 
These responses also indicate that perceived susceptibility and perceived benefit played a role in 
utilization of CD4 count services by WLWHA.  
 
However, concerns were raised over the ability of hospitals to provide CD4 count services. 
A key informant noted that; materials and machines are not readily available (Public health 
physician, age 34) while some respondents cited laboratory logistics as a factor inhibiting 
utilization of CD4 count services. Others cited cost and long waiting list as factors as well as delays 
in getting the result, unavailability of reagents and faulty machines. For the patients attending 
private hospitals, key informants mentioned financial problems as a challenge for women seeking 
to check their CD4 count. These responses were verified by WLWHA who cited difficulty in 
accessing CD4 count services as evident in the following statement made by a WLWHA;  
My recent experience was not so good. I was referred to some other 
places because their machines were faulty at the hospital I registered 
(Mother of 2, age 33). 
 
Another respondent made a statement regarding cost of CD4 count services. Regularly/ I have 
been doing it every time they ask when I have money (Mother of 4, age 37). These statements are 
indication of the low quality of CD4 count services provided in hospitals and that economic 
barriers may inhibit utilization of CD4 count services. 
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5.5 Provision of HAART 
The literature by Kasenga, Hurtig and Emmelin (2010) revealed that some women especially those 
whose sexual partners were aware of their status failed to return for treatment because they were 
afraid of being economically bankrupt and the potential of facing domestic violence. Contrary to 
this finding from literature, this study discovered that acceptance of ARV for treatment and 
prophylaxis was very high with all women and key informants in the study confirming that 
WLWHA took their medication regularly. 
Side Effects of Drugs, Health System Constraints and Socio-Cultural Factors. 
Although key informants unanimously mentioned that there is sufficient use and adherence to 
HAART throughout pregnancy, it was discovered that there are a few gaps. As mentioned by 
Mofenson & Mclntyre (2000) in the literature section of this study, ability to find out HIV status 
early is a great determinant of whether WLWHA will use PMTCT services. A WLWHA states; 
No, I knew my status after my delivery (Mother of 3, age 44). A WLWHA in this situation is very 
likely to transmit HIV to her baby because no measure was taken for PMTCT throughout the 
pregnancy. Some women are said to experience strong side effects from the medication thus posing 
perceived barriers as described in the health belief model which assumes that adherence will be 
reduced in these situations. 
At the health facility level, key informants reported that there are issues like administrative 
bottlenecks, shortage of drug supply and the fact that some women have to buy medication 
whenever it is not available. Sometimes we don’t have certain medication. If we don’t have, they 
need to go and buy (NGO representative, age 25). When asked about their challenges, a key 
informant mentioned; Yes most women still go to TBA to have their child (Data entry clerk, age 
28). For these women, they are not likely to find out their HIV status hence, facing high risk of 
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transmitting HIV to their babies. Some key informants mentioned that the need to swallow tablets 
every day and too many tablets to swallow are also factors hindering effective administration of 
HAART. For example a key informant mentioned factors like; Delay in decision making, patients 
in denial and side effect of drugs (Medical doctor, age 32). Other responses were hospital related 
difficulties such as volume of clients and funding. One notable response by a key informant is that; 
there are some that resist us with excuses like they have been prayed for (M&E officer, age 40). 
This means religious factors can hinder the use of medication by WLWHA. 
As evident in the response from another key informant, payment for antenatal care by 
WLWHA is a factor that can hinder adherence even when HAART is provided free. The HIV 
medication are free but they paid for medication like the antenatal and that is done by the 
client(Data entry clerk, age 28). Therefore payment for other PMTCT services may lower the 
gains achieved in providing free medication to WLWHA. This claim was confirmed by a WLWHA 
who states; it is free, but the transportation to get the medication is expensive (Mother of 3, 33 
years).The responses by key informants were confirmed by WLWHA when most women 
complained about the side effects of HAART. One WLWHA said; previous dosage was once every 
morning and evening but now the dosage has been changed to just every evening and the drug 
seem more potent (Mother of 2, age 33). Other WLWHA who also experienced high perceived 
barriers reported feeling dizzy and having dry lips while another woman narrates her experience 
in the following statement; 
At the onset I usually forget or feel reluctant. I sometimes mix it into 
my meal to enable me take it. But after a while, I became consistent 
and now it feels natural to me (Mother of 3, age 34). 
Another WLWHA said;  
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I have to eat a lot. The pills are very large and I have to take two 
(Mother of 4, age 34). 
5.6 Experiences of WLWHA during Labour and Delivery 
Most WLWHA delivered in a health facility with a few exceptions and some WLWHA who were 
termed un-booked patients attended another health facility for ANC but showed up at a different 
health facility for delivery where their HIV statuses were unknown. In these cases, doctors would 
have no prior information about patient’s history putting the baby at risk of MTCT.  
Un-booked Patients. 
Responses from both key informants and WLWHA revealed that most women who deliver in 
health facilities arrive at the first or second stage of labour. A few WLWHA noted that there was 
no time to get to the hospital so they delivered at home with the help of a midwife. No. it was late 
and I could not go to the hospital, so a hospital staff help me deliver at home (Single mother, age 
34). When asked whether there are women who show up at the health facility for the first time 
during labour, some of the key informants mentioned that there are un-booked patients who did 
not attend antenatal care due to ignorance. Yes. Some do clinic elsewhere but want to deliver here 
because of safe delivery (Graduate volunteer, age 49). Another key informant states; Im aware 
that most do not go for ANC (Public health physician, age 34). One respondent further explained 
that this happens due to finance and the patients are usually worse off. Yes un-booked. They have 
poor outcomes (Medical Practitioner, age 34). They attend traditional birth attendants where they 
are not screened and do not know their status (Public health physician, age 34). Another key 
informant states; 
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Yes. I think it is un-seriousness and some are just afraid that their 
partners would find out/ not taking it seriously/feel reluctant / some 
are hiding so the husband will not know (NGO representative, age 
25). 
In such cases, the WLWHA may not know her HIV status and there may be no time to 
carry out such test when she is at the final stage of labour. Consequently the babies will be at risk 
of being exposed to the HIV. Key informants noted that women usually prefer vaginal delivery to 
caesarean delivery as evident in the following statements by a key informant. Most women here 
are not keen on CS and most women prefer natural delivery irrespective of viral load (Public 
health physician, age 34). Another challenge expressed during labour as suggested in this theme 
is the absence of viral load machines. A key informant confirms this saying; we don’t have viral 
load machine (Social worker, age 45). When asked about her viral load at the time of delivery, a 
WLWHA further corroborated this statement by stating that; I didn’t know then because no such 
test was conducted but I know now (Mother of 4, age 34). 
5.7 Immediate Postpartum Experiences of WLWHA 
At postpartum, WLWHA are expected to receive Nevirapine for their babies for up to 6 weeks and 
septrin for 3 months while the mother is to continue taking ARV. Thereafter, the mothers are to 
attend follow up visits with their babies until the baby is 18 months based on the Nigerian PMTCT 
guideline by the Federal Ministry of Health (2016). At the post-delivery stage, WLWHA and key 
informants noted that mothers continued taking their ARV medication and babies are usually 
administered prophylaxis to prevent transmission of HIV. This aspect of PMTCT was also highly 
utilized and adhered to but some mothers were said not to return for follow up visits with their 
babies because they believed that their babies were negative.  
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Attendance of Follow-up Visits. 
It was found that some WLWHA do not attend follow up visits even though adherence to 
ARV medication is very good. Key informants disclosed that no actual numbers of women 
returning for follow up was recorded and expressed concern that many patients are faced with 
economic hardship that might have affected their abilities to attend follow up visits. A key finding 
in this theme is that there are WLWHA who test their babies at birth and discover that baby is 
negative but they make no further effort to attend follow up visits to check baby’s status. When 
asked whether she attended follow up visits, a WLWHA responded thus; Not anymore/only at 
birth because he was discovered to be HIV negative (Mother of 2, age 34). Another woman who 
attended follow up visits twice mentioned that her baby was not given nevirapine prophylaxis 
because her baby was ok. These have severe consequences for PMTCT. This finding conforms to 
the health belief model that perceived susceptibility of transmission of HIV to the baby has 
significantly reduced which translates to significant decrease in attendance of follow up visit after 
6 weeks postpartum.   
One of the challenges faced by WLWHA after caesarean delivery is that they are instructed 
not to eat immediately they are out of the theatre. This presents a difficulty because they cannot 
take the ARV medication without eating some food as evident in the following response; I had to 
take the drug on an empty stomach since I delivered by CS and could not indulge in heavy foods 
even though the drugs require it (Mother of 3, 34 years). Inability to eat after a caesarean section 
is a perceived barrier which prevents mothers from breastfeeding immediately after delivery and 
the baby may starve in the absence of supplementary food. When this happens, the aim of exclusive 
breastfeeding may be defeated. 
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5.8 Infant Feeding Practices of WLWHA 
Many WLWHA understood the importance of exclusive breastfeeding and preferred it but some 
women stopped exclusive breastfeeding before 6 months against the recommendation of WHO 
and PMTCT guideline of the Federal Ministry of Health (2016). Others opted for exclusive 
formula feeding because of the information they received from health care providers about the 
high risk of MTCT. 
Reasons for Choice of Infant Feeding. 
Respondents in the study were well aware of the benefits of exclusive breastfeeding for PMTCT. 
When asked about their preferred choice of baby feeding, most WLWHA were said to prefer 
exclusive breastfeeding because it is affordable and because of the information provided to 
pregnant women during their ANC talks as suggested in the following; Yes, it makes the child 
healthier and cuts my expenses on baby food (Mother of 3, age 38). In these cases, perceived 
benefit and perceived susceptibility assumptions of the health belief model played a role in 
determining infant feeding choices of WLWHA. A key informant supported this finding by stating 
that; It is less likely for one to get confronted about their baby feeding practice if they are 
breastfeeding (Social worker, age 44). This finding conforms to the literature cited by Eide et al. 
(2006) that the most important consequence of participating in PMTCT program was that women 
experienced difficulty in breast feeding. 
However, key informants noted that mixed feeding is common among WLWHA because 
it is difficult to keep up with. As suggested by a key informant; they find it strenuous (Public health 
physician, age 34). Another mentioned poor lactation and believe that breast milk alone is 
inadequate (Obstetrician and Gynecologist, age 35). Others mentioned that; some of the women 
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work (Obstetrician and Gynecologist registrar, age 33). A key informant summarized the issues 
in the following quote; 
Family pressures to add supplementary feeds, ignorance and poor 
flow of breast milk especially in the first few days after delivery 
(Medical Doctor/Obstetrician and Gynecologist, age 34). 
These factors are common even among HIV negative mothers and have made it extremely difficult 
to achieve the goal of exclusive breastfeeding for the first 6 months. These issues were also 
confirmed by WLWHA in the following quotes; I added water to the breastfeeding so that he will 
be more satisfied (Mother of 2, age 33). This quote indicates that the respondent was misinformed. 
Another quote from a WLWHA shows that community pressure is also a factor that hinders 
utilization of PMTCT services; 
Certain persons expressed their concerns and suggested I switch to 
other food options but I stuck to breastfeeding (Mother of 2, age 33).  
 
A WLWHA adds that; 
Sometimes people suggest that I give him something else but I stuck 
to breastfeeding (Mother of 1, age 35).  
Another challenge is that even though WHO recommended that breast milk and other foods 
should be given between 6 months and 1 year, many WLWHA reported that they stopped 
breastfeeding at 8 or 9 months giving reasons like the baby will bite them and become infected. 
While some women decided to give only formula to their babies for the first 6 months because of 
96 
 
the fear that baby will become infected as depicted in the following quote; Exclusive formula 
feeding. We were informed that breastfeeding has a 50% chance of infecting the child and I did 
not want to take that risk(Mother of 3, age 34). Other women were simply advised by their doctors 
to choose formula feeding as evident in the following quotes; Doctor recommended baby formula 
(Mother of 4, age 36).Baby Formula. Doctors recommend one type of feeding practice (Mother of 
4, age 34). I was instructed to buy NAN baby formula (Mother of 3, age 33).  
For WLWHA who chose exclusive formula feeding, they had to contend with societal 
pressure from those who are unaware of their HIV status. The neighbors wanted to know why I 
was not breastfeeding. I excused myself from the argument with a sound excuse (Mother of 3, age 
34). This response conforms to the finding in the literature that the practice of replacement feeding 
is stigmatized. Women opting to feed their children through replacement feeding are stigmatized 
in numerous cultures thereby complicating adherence by women who prefer to feed their children 
through this means. Identifying them as being HIV positive may result in stigma with 
consequences such as facing ostracism and expulsion from their family members (Horvath et al., 
2010). 
Other WLWHA were faced with the problem of low milk supply and were forced to stop 
exclusive breastfeeding from as early as 3 months while one woman had a cut in her nipples which 
prompted her to stop exclusive breastfeeding at 3 months. Yes I stopped on my own because of 
difficulty of getting the milk out (Mother of 4, age 34). After three weeks the baby was not suckling 
properly so my doctor advised me to stick with infant formula (Mother of 1, age 41). I had a cut in 
my nipples (Mother of 3, age 37). The aforementioned responses regarding mixed infant feeding 
by WLWHA confirm the literature cited by AED (2011) that mothers found exclusive 
breastfeeding difficult to practice especially for working mothers and those with inadequate milk. 
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The same study cited mothers who viewed that water was supposed to be given to babies for 
quenching thirst while others were pressured by family members and friends who could easily 
stigmatize them as being HIV positive. Also similar to this study was the finding by AED (2011) 
that non-breastfeeding was not commonly practiced in the study area because of its association 
with being HIV positive. 
5.9 Effects of Stigma and Discrimination 
When the theme effects of stigma and discrimination was explored, most women stated that they 
did not feel discriminated based on their HIV status. 
Non-Disclosure of HIV Status. 
Similarly, Amuzu (2008) states that people often fail to seek treatment for HIV/AIDS due to fear 
of being discriminated against. Contrary to this literature source, WLWHA in this study did not 
feel discriminated based on their HIV status. This is mostly because they did not disclose their 
status to any other family member except their partners. For example a WLWHA affirmed the 
following statement; No, because I kept the information between my partner and the hospital staff 
(Mother of 2, age 33). Another woman who feared stigma and discrimination disclosed;  
 
Yes, I was living with someone before marriage and I didn’t want 
the person to find out so as not to get stigmatized and driven out of 
the house (Mother of 3, age 33).   
 
This response is also evident in the finding by Amuzu (2008) that in certain instances, people 
living with HIV face rejection by friends, colleagues and may even experience eviction by their 
families. In addition, a key informant stated; Yes RVD patients usually avoid ARV clinics close to 
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their locality due to stigmatization (Obstetrician and Gynecologist, age 35). Some responses were 
related to religious sentiments and ignorance (Obstetrician and Gynecologist, age 35) while others 
mentioned that some women do not want to be publicly seen in ARV clinics (Medical 
Doctor/gynaecology, age 30).  
Other responses were; stigma reduces support from relatives and community (Medical 
doctor, age 32). They cannot come out openly and say their problems (Medical doctor, age 39). 
The level of stigma and discrimination in health facilities plays a significant role in whether women 
return to the hospital for PMTCT. It was found that WLWHA are stigmatized by health workers’ 
attitudes as mentioned by two WLWHA who stated that they experienced stigma from attitude of 
health workers to the extent of making them switch facilities in order to remain anonymous. For 
example, a key informant stated that; some people decide against certain facilities (Social worker, 
age 44). Another respondent noted that; 
when they come for antenatal and they are tested positive, they 
sometimes go elsewhere to register and some of the negative women 
would be looking at them with unease and that can make them not to 
show up for antenatal (NGO representative, age 25).  
In situations where only one family member knows, the death of that member means that support 
for WLWHA has been cut off.  
5.10 Family and Community Support 
Partners of WLWHA did not feel the need to accompany their wives at the early stages of 
pregnancy but during the latter stages, many WLWHA reported being accompanied by their 
partners and relatives. They also reported that they received financial support at the time of labour 
and were accompanied by either their partners or relatives. 
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Male Partner Involvement and Family/Community Support. 
Although all the women stated that their partners were aware of their HIV status, most of 
the women attended antenatal care and other PMTCT services alone. A key informant noted that 
it is very rare to see partners (Public health physician, age 34). Another stated; based on statistics, 
most come alone (Social worker, age 45). These statements were confirmed by WLWHA who 
corroborated that they went alone to the hospitals for antenatal care and HIV tests as well as CD4 
count. For example a woman stated that she attended most times alone (Mother of 4, age 40) while 
another woman mentioned that her husband accompanied her only once (Mother of 1, age 35). Of 
greater concern is the acceptance that there is no place for the man in the PMTCT process. A 
statement made by a WLWHA affirmed this there was no need for him (Mother of 1, age 41). This 
statement is an indication that men are made to believe that their only traditional gender role is to 
provide financial support for their families thus making it difficult for them to perform non-
financial roles. Unlike in the earlier stages of PMTCT, many of the WLWHA were accompanied 
by their partners or relatives to the hospital for labour. It is evident that during delivery, they also 
received financial support from their partners and relatives based on the following response No, 
my cousin and my mom paid (Single mother, age 34). 
5.11 Use of Family Planning Services 
Key informant interviews on the use of contraceptives by WLWHA revealed that acceptance of 
contraceptives by WLWHA is very high with no resistance. 
Reasons for Use of Contraceptives. 
The views of key informants were consistent with WLWHA who adhered to the use of family 
planning services giving reasons such as the need to prevent transmission, planning for healthy 
pregnancy, regulating family size and prevention of unintended pregnancies. These views are 
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supported by some of the responses of WLWHA such as; to plan and build my CD4 count for the 
next baby (Mother of 3, age 30). Modern because its more secured.  Yes because im through with 
child bearing (Mother of 2, age 28). Modern, Not sure of partner’s faithfulness (Mother of 4, age 
34). In all these responses, perceived susceptibility in the health belief model played a greater role 
in the choices of WLWHA to use family planning services offered to them. 
A key issue in this theme is that some of the WLWHA were not using any contraceptives 
even though they do not plan to have any more children as evident in the following responses; No 
this would be the last (Mother of 2, age 33). Having mentioned that she was not using 
contraceptives, a WLWHA states; And I don’t want more children. No im ok (Mother of 4, age 
37). Another WLWHA stated that she was not using contraceptives because she believes it fails 
even though she was not planning to have any more children. No I don’t. im ok with 3(Mother of 
3, age 37). The consequence of this is that where contraceptives fail and a WLWHA gets pregnant, 
she may not find out about her pregnancy early enough to partake in PMTCT to save her baby. 
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CHAPTER 6 
CONCLUSION AND RECOMMENDATIONS 
In chapter one, the questions guiding this research centered on the influence of social support and 
health belief model on utilization and adherence to PMTCT services by HIV positive women in 
Rivers State, Nigeria. The guidelines on PMTCT as laid down by the Nigerian Ministry of Health 
served to provide the scope of defining the various components of PMTCT listed in chapter one. 
These PMTCT components include: Antenatal Care Attendance (ANC), HIV Counselling and 
Testing (HCT), provision of Highly Active Anti-Retroviral Therapy (HAART) and infant feeding 
counselling and support, labour and delivery, Baby testing and treatment as well as family planning 
services. 
This chapter addresses the extent to which the research objectives were met by discussing 
the findings related to each objective. Recommendations were also formulated with regard to 
future applications of the research findings and their implications on social development and 
policy. This will provide the Ministry of Health with information on the assistance and guidelines 
that can be given to health care providers to enable them to implement the PMTCT program based 
on an understanding of the plight of WLWHA. It will also provide WLWHA with the necessary 
information on the need to adhere to PMTCT. Finally, the chapter discussed limitations to this 
research. 
6.1 Conclusions 
The first objective of this research was to explore the nature of PMTCT service utilization and 
adherence in Rivers State, Nigeria. Responses from both key informants and WLWHA revealed 
that utilization and adherence were very high. There were hardly any WLWHA who dropped out 
in the PMTCT process.  
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 The second and third objectives which were to explore the factors influencing utilization 
and adherence of PMTCT services were captured in the reasons most frequently cited for WLWHA 
returning to health facilities for antenatal care, HIV tests and follow up. Even though the research 
revealed low social support for WLWHA especially at antenatal care, it appeared that social 
support was not the major reason for high PMTCT utilization and adherence. It was found that 
these factors are related to the belief that their babies will be negative and they will also live longer. 
These conform to the main tenets of health belief model described in chapter two. Specifically, 
perceived seriousness and perceived susceptibility were the major influencing variables for 
utilization and adherence of PMTCT services.  
 
The fourth objective which sought to discuss the challenges facing WLWHA attending 
PMTCT programs was captured in all the themes that emerged. It appeared that health system 
constraints, were the major factors hindering health care providers from effectively providing 
PMTCT services such as unavailability of test kits, ARVs stock-outs, staff shortage was also a 
challenge resulting in patients waiting long hours to be attended to. Another challenge revealed in 
the themes discussed was socio-economic factors. It appeared that despite having a legal plan and 
framework to ensure that PMTCT services are available and free, the study revealed transport 
costs, payment for CD4 count and antenatal care as major socio-economic factors hindering 
HAART administration as well as the financial costs of formula feeding for women who would 
have preferred exclusive formula feeding. 
 The influence of these factors results in costs being imposed on HIV positive women and 
is made worse by financial dependence on their partners and family. Again, these factors did not 
affect the willingness or ability of WLWHA to seek and adhere to PMTCT services because of 
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their perceived seriousness and perceived susceptibility. These factors barely influenced utilization 
and adherence because WLWHA believed that they and their unborn babies were highly 
susceptible to HIV and were therefore more likely to take preventative measures. It therefore 
follows that perceived barrier in the health belief model did not influence PMTCT utilization and 
adherence. 
The realities confronting WLWHA as suggested in this research provided examples of 
instances where fear of stigma, discrimination and abandonment resulted in lack of disclosure of 
HIV status even though this did not affect the use of PMTCT services. The main socio-cultural 
factors in this study were more likely to influence PMTCT use and adherence and have potential 
outcomes such as social isolation. Inevitably, cultural beliefs are said to influence infant feeding 
choices and the use of contraceptives which lead to high risk of transmitting HIV to the new born.  
6.2 Recommendations 
It is recommended that further research on PMTCT should look into what the priorities should be 
for an effective PMTCT program. In the researcher’s opinion, efforts should be made by the 
Nigerian Ministry of Health to train more health care staff for PMTCT services such as HCT in 
public health facilities. This will eliminate long queues in clinics and reduce the burden of health 
care staff that are responsible for both PMTCT service provision and other health care needs of 
clients.     
 Varga, Sherman and Jones (2006) mention that social and community factors such as 
addressing HIV/AIDS stigma, improving awareness of PMTCT facts, addressing gender relations 
and encouraging male participation are particularly important for improving utilization to PMTCT 
services. This requires stronger efforts by nurses and midwives to co-ordinate meetings with HIV 
positive women who are faced with similar situations. In this way, they can share their experiences 
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and coping strategies therefore, becoming more confident in relating with their partners and 
families. Campaigns could be organized by community organizations and the media could be used 
to create community awareness on some of the factors hindering PMTCT utilization. This will 
generate support for HIV positive women who are threatened by stigmatization.   
 Poverty reduction is also considered as a gender sensitive factor in this research and it is 
important because it is one of the main factors and consequences of HIV/AIDS as mentioned by 
Whiteside (2002). Therefore, directly tackling poverty should remain one of the primary goals of 
public policies thereby enabling women to afford food and transport costs for visiting health 
facilities (Tladi, 2006; van Donk, 2002; Barnett & Whiteside, 2007). In this respect the researcher 
recommends partnership through communication with community organizations, Ministry of 
Social Development, Ministry of Health and National Agency for the Control of AIDS. This will 
ensure access to social grants for women in resource poor settings and allow policy makers to 
explore the possibility of bringing PMTCT services closer to the under resourced communities. 
Further research is needed to explore intensely into them. For reasons of practicality and to get the 
most experienced health care providers and NGO representatives, purposive sampling was used. 
A wider sample may have generated more varied results. 
Since perceived susceptibility and seriousness play the greatest roles in PMTCT utilization 
and adherence, it is recommended that the Nigerian government should more attention to public 
health approaches such as the structured mentor mother programs proposed by Sam-Agudu et al. 
(2017). This will ensure retention in care and viral load suppression for mothers at postpartum and 
will complement on-going biomedical approaches to ensuring optimal utilization and adherence 
to PMTCT services. In line with this, other recommendations deduced including those made by 
key informants for strengthening PMTCT practices in Nigeria are: 
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 WLWHA at postpartum regardless of babies’ HIV status should be required to attend 
scheduled follow up visits with their babies up to 18 months until doctors have certified 
the babies negative to ensure that the babies born to WLWHA remain negative. 
 For pregnant women who appear in the health facility for the first time at the time of labour, 
effort should be made to find out their antenatal history from the initial health facility in 
order to know if there are any complications and HIV status including viral load. 
 CD4 count and viral load machines should be procured and provided to all government 
owned health facilities and effort should be made to ensure that private health facilities 
comply with this standard. 
 In order to address the issue of side effects of ARV medication, it is necessary to prescribe 
the brands that are taken only once daily because WLWHA feel these are more potent than 
those taken 2 or 3 times daily. 
 Male partner and community support during early stages of pregnancy should be 
encouraged in addition to support provided at the time of delivery to ensure that WLWHA 
follow instructions made by health providers. 
 To ensure that all WLWHA exclusively breast feed for 6 months, certified, trained lactation 
consultants should be made available and accessible to WLWHA at the time of delivery 
and nurses should inform and encourage them to attend consultation sessions. This will 
enable WLWHA address any issues they face with breast milk supply. 
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Appendix 2: Transcript of Interviews 
Transcript of Interview for WLWHA at Postpartum 
Introduction: My name is Fadila Jumare. I am a PhD student at the department of social 
development in University of Cape Town, South Africa. 
Interview Protocol: I would like to obtain information from you about your use of and adherence 
to PMTCT services during your pregnancy and after you have delivered your baby. The interview 
will not be longer than one hour and you have the right to withdraw from participating for any 
reason without consequences. Any information you provide will be kept in the strictest confidence 
and your identity or that of your NGO will not be revealed in any way. Do you have any questions? 
Recording: I would like to record the interview so that I will not have to take lots of notes while 
we talk. Would that be a problem for you? I assure you that only the researcher and supervisors 
will listen to the recording. Please speak clearly so that we can hear what was said on the tape. 
 
Thank you for agreeing to participate in this interview. I really appreciate the opportunity. 
 
DEMOGRAPHIC INFORMATION 
 
Participant ID: …………WLWHA 1…..……….. 
 
Age: ………33years……………………………… 
 
State and Local Government Area: …Abia…State..      Place of residence: Port Harcourt, Rivers 
State. 
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Language: ………Igbo……………………    Tribe or ethnic group: ……Igbo Etche…………... 
 
Place of birth: ………Abia…State…………………………………  
 
Date of birth of your 1st child: …14th July, 2008………… 
 
Where was your last baby born? ……28th March, 2015…… 
Interview Guide 
(Probe:  
 Are you married? Yes 
 Are you living with your partner? Yes 
 Is this your first pregnancy? No 
 If No, how many other children do you have? 2 Boys 
 ___I previously had a miscarriage in October 2016, but I am currently pregnant.  So 
my children are two in total now._________ 
1. Tell me about your visits to the clinic during pregnancy (Antenatal Care (ANC). When did 
you attend your first ANC visit? 
(Probe:  
 How many weeks pregnant were you then?2 months (8 Weeks) 
 How old were you at the first visit? 30 
 How often did you attend? Weekly (every Saturday) 
 Did you attend at least four times during your pregnancy? Why? Or why not?Yes. I attended 
because the life of my unborn child was very important to me 
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 Did you follow all the guidelines given by the instructors? Why? Or why not? Yes. I followed 
all instruction given me because I wanted to live long. 
 Did your partner accompany you to antenatal care visits? Yes 
 ________________________________________________________________________I 
discovered I was HIV positive when I was pregnant with my second child. My husband was 
also tested and confirmed positive for the virus. We were, thereafter placed on drug 
therapy.____________________________________________________________________
_ 
2. Next, I want to ask about HIV testing. Did you test for HIV during your pregnancy?  
(Probe:  
 When did you do the HIV test during antenatal care visit?At my first visit (my 
registration visit) 
 Is this the only time you’ve tested for HIV? Yes 
 Was that when you knew your status?Yes 
 Did the doctors recommend any further tests? Did you do them? No, the doctors did 
not recommend any further tests 
 Did you know before then? No 
 Did you go with your partner? If No, who accompanied you? Yes 
 Did you disclose the results with your partner or anyone close to you? Yes 
 Do you know your partner’s HIV status? Yes 
 Does he know yours?) Yes 
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3. Next I want to ask about CD4 count. When did you get your CD4 count? Six Months after 
registration 
(Probe:  
 What were your experiences in accessing CD4 count services? My Recent experience 
was not so good. I was referred to some other places because their machines were 
faulty at the hospital I registered  
 Were you referred to go somewhere else? Yes 
 Did you go? Yes 
 How often did you test for CD4 count? Did you go for follow up counts? Why or why 
not? Every Six months 
 What was the result of the first count? 500+ 
 Who went with you to get the CD4 count? Did your partner accompany you? My 
Partner/yes 
 Did they recommend HAART for life? Yes, they did 
 ____________________________________________ 
 
4. When did you start taking your PMTCT medication (HAART for life)? Immediately it was 
issued 
(Probe:  
 Did you take it throughout your pregnancy? If No, why? Yes 
 For how long did you take it? Throughout the pregnancy 
 Did you take the recommended dosage? Yes 
 Did you take it as you were told? Yes 
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 What was the dosage? Once every morning and evening 
 Did you have to take it every day? yes 
 Did you receive support to take it every day? By who? If no, why not? yes 
 Who paid for it? Free 
 What challenges did you encounter while taking HAART medication? No 
 ______Previous dosage was once every morning and evening but now the dosage has 
been changed to just every evening and the drug seem more potent 
_____________________________________________________________________
_____________________________________________________________________ 
 
5. Let’s talk about labour. Did you deliver at a health facility? Why or why not? Yes 
(Probe:  
 When did you arrive at the health facility?Labour started at 1am and I went to the 
hospital at 4am but I put to bed at about 9-10am.  
 Did you receive the ARV prophylaxis drug during labour or delivery to save your baby? 
 What was your viral load at the time of delivery? I didn’t know then (because no such 
test was conducted) but I know now. 
 Did you deliver through Caesarean section? Who paid for the delivery?No I delivered 
normally/My partner 
 Who went with you to the hospital for delivery? Did your partner accompany you? My 
partner and my siblings 
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6. Next, I would like to discuss what happened after you delivered. Was the baby injected with 
the ARV medication after delivery? If no, why? Yes, the baby was injected immediately it was 
delivered 
(Probe:  
 Are you taking PMTCT drugs after delivery? Why or why not? Yes/to maintain my 
health 
 Is your baby also taking? For how long? Not anymore/only at birth (because he was 
discovered to be HIV negative) 
 Who pays for the drugs? Do you have any support from the community or any one 
close to you?  
 What challenges do you encounter while taking the medication? No 
 How do you resolve them? 
 Did you attend follow up visits through delivery to 18 months? How many times? No, 
but he was tested at birth. 
______________ child was tested once at birth and found negative at birth but no or 
only one follow up visit was attended to check baby’s status. 
_____________________________________________________________________
______________________ 
 
7. Please tell me your experience during the first six months of infant feeding. Did they 
recommend any particular infant feeding practice? Did you follow the instruction? I breastfed 
for six months. 
(Probe:  
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 Are you doing exclusive breast feeding, exclusive formula feeding? Why? I added 
water to the breastfeeding so that he would be more satisfied 
 Did you follow through with your choice? Why or why not? yes 
 Did you breastfeed following delivery? yes 
 Did you stop exclusive feeding at 6 months? Why? If no, when did you stop? Who told 
you to stop? Your husband or is it an instruction from the hospital?  I stopped 
breastfeeding after nine months on the instruction of the hospital. 
 Will you continue exclusive feeding? Why? Yes, when I deliver again 
 How old is your baby now? 2 years old 
 Did you breastfeed after six months? Why? Yes, because the child desired it 
 What major constraints did you face while exclusively feeding your baby?) Certain 
persons expressed their concerns and suggested I switch to other food options but I 
stuck to breastfeeding. 
_______________breastfed after 6 months against WHO 
recommendation_______________________________________________________
_______________________________________________________ 
8. Next, let’s talk about baby testing. Has your baby been tested? If no, why? Yes 
(Probe:  
 When was the baby tested? At Birth 
 What was the result? Negative 
 Did you do the second test after 18 months? If no, why? No, just at birth (only after 6 
months) 
 What was the result?  
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 What is the status of your other children?) Negative 
 
9. Next I want to ask about HIV medication for the baby who tested positive. Is the baby on 
HAART drugs for life? If no why? 
(Probe:  
 Is it easy to get the medication?  
 What are some of the challenges you encounter in getting the medication? Is it always 
available? 
 Do you get any support from the community or anyone close to you while trying to 
access the medication? 
 Is your baby accepting it?  
 Who pays for it?) 
 
10. Are you using any family planning? If no, why?No but we plan on stopping at the third. 
(Probe:  
 Why are you using family planning? 
 Are you using modern or traditional methods? Why? 
 Do you plan to have any more children? Why? Or why not?) No, this would be the last 
 _____________________________________________________________________
________________________________________________________________ 
 
11. Do you experience any form of stigma and discrimination based on your HIV status?No, 
because I kept the information between my partner and the hospital staff. 
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(Probe: 
 Do you think this has affected your use and adherence to PMTCT services? How? 
 
No stigma experienced because status has not been disclosed to other family 
members_____________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
12. Observation: 
 _____________________________________________________________________
_____________________________________________________________________
______________________________________ 
12. General Comments: 
13. ___________________________________________________________________________
______ 
 
Thank you for your time and the information you have shared with me. 
 
Transcript of Interview for Key Informants from NGO Representatives 
Introduction: My name is Fadila Jumare. I am a PhD student at the department of social 
development in University of Cape Town, South Africa. 
Interview Protocol: I would like to obtain information from you about the factors influencing 
utilization and adherence of PMTCT services. The interview will not be longer than one hour and 
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you have the right to withdraw from participating for any reason without consequences. Any 
information you provide will be kept in the strictest confidence and your identity or that of your 
clinic will not be revealed in any way. Do you have any questions? 
Recording: I would like to record the interview so that I will not have to take lots of notes while 
we talk. Would that be a problem for you? I assure you that only the researcher and supervisors 
will listen to the recording. Please speak clearly so that we can hear what was said on the tape. 
 
Thank you for agreeing to participate in this interview. I really appreciate the opportunity. 
 
DEMOGRPHIC INFORMATION 
  
Participant ID: ………NGO 1………………………………….. 
 
Age: ……………………40…………………………………… 
 
State: ………Ebonyi…………………………………………………. 
 
Place of residence: …………Port Harcourt, Rivers State………………………………… 
 
Local Government Area: ………Etchet………………………………  
 
Place of work: ……………………Health of the Sick Hospital…… 
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Language: …………………Igbo………………………………….. 
 
Tribe or ethnic group: …………Igbo……………………………… 
Interview Guide 
1. Can you tell me about yourself? 
 (Probe: 
 What is your level of education?  
 What are your qualifications?  
 What is your occupation? M & E Officer 
 How many years of experience do you have in the HIV/IDS sector/program? 15 
Years 
 For how long have you been working in this NGO? 8 years 
 __________________________________________________________________
__________________________________________________________________
_______ 
2. Please tell me about the attitude of WLWHA towards antenatal care attendance?  
(Probe: 
 When do most WLWHA attend their first ANC? Some come early and some late 
 At how many weeks of pregnancy do most WLWHA begin ANC? Like I said, some 
come early and some come later 
 How often do most WLWHA attend ANC?  
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 Do most WLWHA attend at least four times during their pregnancy? Why? Or why 
not? Every Friday is ANC in this Hospital and some like to come every Friday, 
some twice a month or once a month but it is always more than four times. 
 Do the partners of most WLWHA accompany them to antenatal care visits? Some 
partners do 
 What can be done to improve ANC attendance? Price of the booking is a concern 
 Is the NGO doing anything to improve ANC attendance? Yes, we enlighten them 
on the importance of it 
Not all women attend antenatal care 4 times. Some attend even more than 4 times. 
Price of antenatal care may prevent some women from 
attending__________________________________________________________
__________________________________________________________________
______ 
3. What are your views about uptake/ of HIV Counseling and Testing (HCT) by WLWHA.  
(Probe: 
 Do most WLWHA accept the HIV test? Yes  
 Do most WLWHA return for their test results? Yes 
 When do most of the WLWHA find out their status? Some find out here while some 
already know. HIV test for pregnant women is mandatory here. 
 Do most WLWHA already know their status before ANC? Some know while some 
don’t. 
 Do most WLWHA go for HIV tests with their partners? If No, who accompanies 
them? We tell them to bring their partners 
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 Do the partners of most WLWHA take the HIV test? We encourage it and they 
respond to it 
 If no, do they disclose the results with their partners or anyone close to them? Some 
disclose it themselves but in case they are afraid to, we invite their partners and take 
them through counselling where we expose the result to them 
 Do most WLWHA know their partners’ HIV status? Yes, but with the permission 
of the partner 
 What can be done to improve HIV testing utilization and adherence? There is no 
issue with the testing nor is there any issue with compliance from the people.  
 What is your NGO doing to improve HIV testing utilization and adherence?  
 ________We are doing a lot to make them take the test 
__________________________________________________________________
______________ 
 
4. Next, I want to talk about CD4 count.What is your view about the general uptake with 
CD4 count by WLWHA? 
(Probe:  
 Do most of the women go to receive their CD4 count?  
 What are the challenges with accessing CD4 count? Sometimes we run out of 
reagents 
 Are they referred to other facilities for CD4 count services? Yes, they are 
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 What should be done to improve CD4 count services? They have to ensure the 
reagents are always available 
 ______________________hospital related 
difficulties________________________________________________________ 
5. Tell me about the use of HAART for life. What are the current recommendations for 
initiating HAART for pregnant WLWHA? As soon as they are tested, they start taking the 
drug 
(Probe:  
 Do most WLWHA take their medication throughout their pregnancy? If No, why? 
They take it throughout their life time 
 What are the challenges? None in this hospital 
 For how long on average do most WLWHA take their medication? A lifetime  
 Do most WLWHA take the recommended dosage? Yes 
 Do you experience any resistance from WLWHA in administering the medication? 
There are some that resist us with various excuses like they have been prayed for. 
 Who pays for medication for most WLWHA? The government  
 Do most WLWHA receive any support from their partners or community in 
accessing the medication?  
 Is the medication readily available? Yes, it is 
 What are the problems hindering effective administration of PMTCT medication? 
None 
 Have these problems always been there? 
152 
 
 Are there any improvements? 
 What can be done to improve the problems?  
 What is the NGO doing to address the problems?)  
_____religious factors can hinder the use of medication____________________ 
6. Let’s talk about labour. Do most WLWHA registered in your NGO return to the hospital 
for labour and delivery? Why or why not? 
(Probe:  
 At what stage of labour do most WLWH arrive at the clinic?  
 Do you know of WLWHA who are seen for the first time at the time of delivery or 
at postnatal stage? Why do you think this happens? Yes, there are. I think it is a 
poverty thing 
 Do most WLWHA with high viral load accept Caesarean section at delivery? Why 
or why not? CS is by choice 
 Do most WLWHA with low viral load accept natural delivery? Why or why not?) 
 __________________________________________________________________
________________________________________________________________ 
 
7. Next, I want to discuss what happens after WLWHA have delivered. Are their babies 
injected with ARV prophylaxis medication immediately after delivery? Yes, as soon as a 
HIV positive woman delivers, we give the baby medication for six weeks (Nevirapine 
syrup for 6 weeks, test after 6 weeks) 
(Probe:  
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 Do most mothers continue taking PMTCT medication after delivery? For how 
long? Yes 
 Are the babies of most WLWHA also taking PMTCT medication? Yes 
 For how long?  
 Do most WLWHA take the recommended dosage? 
 Is there resistance in uptake of the PMTCT medication?  
 Has this resistance always been there?  
 Are there any improvements in uptake of PMTCT medication?  
 What can be done to improve uptake of PMTCT medication by WLWHA? 
 What is the NGO doing to address the problems? 
 Do postpartum WLWHA attend follow up visits through delivery to 18 months? 
How many times?) 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
8. Tell me your experience with exclusive infant feeding practices of WLWHA.  
(Probe:  
 What is the recommended infant feeding practice by the health providers in this 
state? We recommend six months exclusive breastfeeding 
 Do most WLWHA adhere to it? Yes 
 What is the most common infant feeding practice? Why do you think it is common? 
Some do formula feeding and some do breastfeeding 
 Do most WLWHA breastfeed following delivery? Yes  
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 Is mixed infant feeding common among WLWHA? Why is it so? Yes, in cases 
where the women complain they cannot cope with just breastfeeding 
 Do they stop exclusive infant feeding at 6 months? Why? We recommend it so they 
can add other things to the baby’s food catalogue. Poverty 
 When do most WLWHA stop exclusive infant feeding?  
 Do you find WLWHA still doing exclusive infant feeding after 6 months? Why?  
 What major constraints do you encounter in ensuring that they exclusively feed 
their infants for 6 months? Ignorance, mostly 
________We encourage them to feed the baby with breast milk up till one year since there is no 
fear of contracting the virus 
______________________________________________________________________________
_______________________________this is not a WHO recommendation___ 
9.  Let’s talk about baby testing. Do most WLWHA get their babies tested for HIV after 
delivery? Why or why not? Yes, after six weeks 
(Probe:  
 Do most WLWHA return for the results? Why or why not? Yes 
 Do most WLWHA test their babies at 18 months? Why or why not? Yes, to be sure 
the bay is actually free 
______________________________________________________________________________ 
10. Next I want to ask about HIV medication for babies with positive results. Do you place 
them on HAART medication for life? Why? Yes  
(Probe:  
 How much does the medication cost? It is free 
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 Do you experience any resistance from the mothers buying the medication? None 
 Are the babies accepting it? Yes 
 Is there any resistance in the uptake of PMTCT medication by babies born to 
WLWHA?  
 Has this resistance always been there?  
 Are there any improvements?  
 What can be done to improve uptake of PMTCT medication for the babies?  
 What is the NGO doing improve uptake of PMTCT medication?) 
______________________________________________________________________________
______________________________________________________________________________
________ 
11. Next, I would like to discuss about the use of family planning by WLWHA.  
(Probe:  
 Do you recommend family planning to WLWHA? Why or why not? Yes 
 Do most WLWHA opt for modern or traditional methods? That’s personal to them 
 Do most WLWHA adhere to their chosen method? Yes  
12. Do you think WLWHA are experiencing stigma and discrimination? They do but we try to 
encourage them 
(Probe:  
 Do you think that is affecting adherence and use of PMTT services? How? Yes 
13: Observation: 
______________________________________________________________________________
_ 
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13. General comments 
________________________________________________________________________
________________________________________________________________________
__________________________ 
Thank you for the time and information you have shared with me. 
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Transcript of Interview for Key Informants from Health Care Providers 
Introduction: My name is Fadila Jumare. I am a PhD student at the department of social 
development in University of Cape Town, South Africa. 
Interview Protocol: I would like to obtain information from you about the factors influencing 
utilization and adherence of PMTCT services in your clinic. The interview will not be longer than 
one hour and you have the right to withdraw from participating for any reason without 
consequences. Any information you provide will be kept in the strictest confidence and your 
identity or that of your clinic will not be revealed in any way. Do you have any questions? 
Recording: I would like to record the interview so that I will not have to take lots of notes while 
we talk. Would that be a problem for you? I assure you that only the researcher and supervisors 
will listen to the recording. Please speak clearly so that we can hear what was said on the tape. 
 
Thank you for agreeing to participate in this interview. I really appreciate the opportunity. 
 
DEMOGRPHIC INFORMATION 
 
Participant ID: …Dr 1..……………………………………….. 
 
Age: ………………………34 years old……………………… 
 
State: …………………Rivers State……………………………. 
 
Place of residence: ………………Rummuobiakani…………… 
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Local Government Area: ………Port Harcourt…………………  
 
Place of work: ………………Health of the Sick Hospital……… 
 
Language: ……………………………English………………….. 
 
Tribe or ethnic group: …………Ogoni Rivers State……………… 
Interview Guide 
1. Can you tell me about yourself? 
(Probe: 
 What is your level of education? Postgraduate 
 What are your qualifications?MBBS, MSc University of Port Harcourt 
 What is your occupation?I am a Public Health Physician 
 How many years of experience do you have in the HIV/IDS sector/program?3 years 
in HIV/AIDS Started with AHNI as a volunteer then FHI 360 USAID under 
SIDHAS project then AHNI Global fund project. For how long have you been 
working in this clinic/hospital?I have been with the NGOs for the past 3 years.  
 __________________________________________________________________ 
 
2. Please tell me about the attitude of WLWHA towards antenatal care attendance?  
(Probe: 
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 When do most WLWHA attend their first ANC? Most women register between the 
2nd -3rdtrimester. More volunteers to reduce time spent in clinic. At how many 
weeks of pregnancy do most WLWHA begin ANC? On the average 16-20 weeks 
after they feel sure they are pregnant and the pregnancy is stable. 
 How often do most WLWHA attend ANC? Most women attend monthly ANC here. 
 Do most WLWHA attend at least four times during their pregnancy? Why? Or why 
not? Yes though working with mothers occasionally miss their appointments but 
adherence is good. 
 Do the partners of most WLWHA accompany them to antenatal care visits? No 
very rare to see partners. 
 What can be done to improve ANC attendance? More incentives for women. 
 Is the clinic doing anything to improve ANC attendance? Yes they are doing well 
in trying to provide staff but the gap is not closed yet. 
 __________________________________________________________________ 
3. What are your views about uptake/ of HIV Counseling and Testing (HCT) by WLWHA.  
(Probe: 
 Do most WLWHA accept the HIV test? The test is still being accepted with 
scepticism 
 Is there any improvement in HCT acceptance?  
 Do most WLWHA return for their test results? Yes they do. 
 Is that when most of the WLWHA find out their status? Same day result is practiced 
here. 
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 Do most WLWHA already know their status before ANC? A few of them already 
know. 
 Do most WLWHA go for HIV tests with their partners? If No, who accompanies 
them?No they usually come alone. 
 Do the partners of most WLWHA take the HIV test?Only after persuasion. 
 If no, do they disclose the results with their partners or anyone close to them? Yes 
they do 
 Do most WLWHA know their partners’ HIV status? Most do but a few do not 
continue 
 What can be done to improve HIV testing utilization and adherence in your clinic?  
 What is the clinic doing to improve HIV testing utilization and adherence?) 
 __Provider Initiated Counseling and Testing (PICT)  with the opt out approach 
ensuring that everyone who steps in for ANC is 
tested_____________________________________________________________
___ 
 
4. Next I want to talk about CD4 count. When do you usually reveal the result of their first CD4 
count?  
(Probe:  
 What is your view about the general uptake with cd4 count by WLWHA?It is 
generally accepted  
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 Do most of the women go to receive their CD4 count? as most people wish to 
know their CD4 as an assessment of improvement or decline. 
 What are the challenges with accessing CD4 count?Materials and machines are 
not always readily available. 
 Do you refer them to other facilities for CD4 count services?Yes they are referred 
to the closest center with CD4 machine eg Obio cottage, military hospital, etc. 
 What should be done to improve CD4 count services? 
_Ensuring that men and materials are available at all 
time._____________________________________________________________
______________________________________________________________ 
 
5. Tell me about the use of HAART for life. What are the current recommendations for initiating 
ARV medication for HIV pregnant WLWHA?  
(Probe:  
 Do most WLWH take their medication throughout their pregnancy? If No, why? 
Yes they do. Occasional misses are noted especially due to TDF 600mg side effects. 
 If no what are the challenges? 
 For how long on average do most WLWHA take their medication? They take them 
throughout the period of pregnancy 
 Do most WLWHA take the recommended dosage? Yes 
 Do you experience any resistance from WLWHA in administering the medication? 
Not much only in starting treatment. 
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 What are the problems hindering effective administration of PMTCT medication? 
 Who pays for medication for most WLWHA?NGOs pay. 
 Do most WLWHA receive any support from their partners or community in 
accessing the medication?Not much support I would say. 
 Is the medication readily available? Yes it is with few gaps. 
 Have these problems always been there? 
 Are there any improvements? 
 What can be done to improve the problems? More adherence counselling 
 What is the clinic doing to address the problems?) Yes ongoing adherence at every 
point been emphasized. Yes use of mentor mother’s and… 
 __________________________________________________________________
__________________________________________________ 
 
6. Let’s talk about labour. Do most WLWHA registered in your clinic return for labour and 
delivery? Why or why not? 
(Probe:  
 At what stage of labour do most WLWH arrive at the clinic? Most come at the 
second stage of labour. 
 Do you give them ARV prophylaxis drug during labour or delivery?Yes 
 Do you know of WLWHA who are seen for the first time at the time of delivery or 
at postnatal stage? Why do you think this happens?Im aware that most do not go 
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for ANC. They attend traditional birth attendants where they are not screened and 
do not know their status. 
 Do most WLWHA with high viral load accept Caesarean section at delivery? Why 
or why not?Most women here are not keen on CS 
 Do most WLWHA with low viral load accept natural delivery? Why or why not?) 
 __Most women prefer natural delivery irrespective of viral 
load__________________________________________________ 
 
7. Next I want to discuss what happens after WLWHA have delivered. Are their babies injected 
with ARV medication immediately after delivery? 
(Probe:  
 Do most mothers continue taking PMTCT medication after delivery? For how 
long? They are given Nevirapine. 
 Are the babies of most WLWHA also taking PMTCT medication? For how 
long?Yes they are, 6 weeks then DBS then Septrin. 
 Do most WLWHA take the recommended dosage? 
 Is there resistance in uptake of the PMTCT medication? No there is no resistance 
 Has this resistance always been there?  
 Are there any improvements in uptake of PMTCT medication? Yes they are 
improving 
 What can be done to improve uptake of PMTCT medication by WLWHA?Constant 
monitoring of women 
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 What is the clinic doing to address the problems?Ensuring that they pick up their 
drugs when due 
 Do postpartum WLWHA attend follow up visits through delivery to 18 months? 
How many times?) 
______________________________________________________________________________
_____________________________________________________________________________ 
8. Tell me your experience with exclusive infant feeding practices of WLWHA.  
(Probe:  
 What is the recommended infant feeding practice by the health providers in this 
state? Breastfeeding 
 Do most WLWHA adhere to it? Yes  
 What is the most common infant feeding practice? Why do you think it is 
common?they prefer breastfeeding 
 Do most WLWHA breastfeed following delivery?Yes 
 Is mixed infant feeding common among WLWHA? Why is it so? YesIndecision 
about infant feeding before delivery 
 Do they stop exclusive infant feeding at 6 months? Why? When do most WLWHA 
stop exclusive infant feeding? Most before 6 months say it is stressful at 3 months 
 Do you find WLWHA still doing exclusive infant feeding after 6 months? Yes a 
few Why?Inadequate information 
 What major constraints do you encounter in ensuring that they exclusively feed 
their infants for 6 months?)They find it strenuous  
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______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
_ 
9.  Let’s talk about baby testing. Do most WLWHA get their babies tested for HIV after 
delivery? NoWhy or why not? No test kits 
(Probe:  
 Do most WLWHA return for the results? Why or why not? Yes they return for 
results 
 Do most WLWHA test their babies at 18 months? Why or why not?)Most test of 
DBS are done at 6 weeks and after that if positive most do not bother to repeat. 18 
months testing is rather rare because of DBS 
______________________________________________________________________________
____ 
10. Next I want to ask about HIV medication for babies with positive results. Do you place 
them on HAART medication for life? Yes Why? 
(Probe:  
 How much does the medication cost? Free courtesy of NGO 
 Do you experience any resistance from the mothers buying the medication? No 
 Are the babies accepting it? Yes 
 Is there any resistance in the uptake of PMTCT medication by babies born to 
WLWHA? NO 
 Has this resistance always been there? NO 
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 Are there any improvements? Yes 
 What can be done to improve uptake of PMTCT medication for the babies? 
Availability is the problem 
 What is the clinic doing improve uptake of PMTCT medication?)Improving our 
supply 
______________________________________________________________________________
______________________________________________________________________________
______ 
11. Next, I would like to discuss about the use of family planning by WLWHA.  
(Probe:  
 Do you recommend family planning to WLWHA?Yes contraceptiveWhy or why 
not?For prevention of transmission 
 Do most WLWHA opt for modern or traditional methods?Traditional methods 
 Do most WLWHA adhere to their chosen method?) 
12. Do you think WLWHA are experiencing stigma and discrimination? 
(Probe:  
 Do you think that is affecting adherence and use of PMTT services? How?Customs 
and tradition 
13: Observation: 
______________________________________________________________________________
_______________________________________________________________________ 
13. General comments 
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________________________________________________________________________
__________________________________________________________ 
 
Thank you for the time and information you have shared with me. 
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Appendix 3: Interview Information and Informed Consent Forms 
Informed Consent Forms 
RESEARCHER’S DETAILS 
 
Title of the Research Project FACTORS INFLUENCING 
UTILIZATION AND ADHERENCE 
TO SERVICES FOR PREVENTION 
OF MOTHER TO CHILD 
TRANSMISSION OF HIV IN RIVERS 
STATE, NIGERIA 
Investigator’s Details FADILA JUMARE 
 
Address NO 13 ADAMU HUSSAINI STREET 
DANTATA ESTATE, KUBWA, ABUJA 
Contact Telephone Number +2348096387247 
Email fjumare@gmail.com 
INTERVIEW INFORMATION 
Aim  The researcher is studying to: explore 
factors that influence utilization and 
adherence to PMTCT services by HIV 
positive women in Rivers State, 
Nigeria 
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The information will be used for PhD 
thesis. 
Procedures Structured in-depth interviews will be 
conducted with participants. Verbal, open 
and direct questions will be used to obtain 
participants’ views on factors influencing 
and utilization and Adherence to PMTCT 
services by WLWHA 
Risks There are no risks involved as a result of 
participating in this study. 
Possible Benefits The information collected is geared 
towards improving PMTCT services. 
Anonmity Participants’ identities will not be revealed 
in any discussion, description or scientific 
publications by the investigators. 
Confidentility All information collected will be strictly 
confidential. The data will be secured, 
password, coded and only accessible to the 
researcher, the supervisor and the field 
worker. 
Voluntary Participation/ Refusal/ 
Discontinuation/Privacy 
Participation in this study is voluntary and 
any decision whether or not to participate 
will  in no way affect their present or future 
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relationship with the supervisor/service 
provider. Even if you have decide not to 
participate, you have the right to terminte 
at any time without jeoprdising your 
reltionship with you supervisor/service 
provider. The interview will be conducted 
in  a private place where noone else will 
listen to the converstion. 
Please Answer the Following Questions by Circling your Responses: 
Have you read and understood the information 
about the above study?                     
       YES                         NO 
Have you been able to ask questions about the 
study?             
       YES                         NO 
Have you received enough information about this 
study?          
       YES                         NO 
Do you understand that you are free to withdraw 
your participation in this study at any time without 
giving any reason and without any effect on your 
relationship with your supervisor/ service 
provider?         
       YES                         NO 
Do you understand that your responses will be 
made anonymous before they are analyzed? 
       YES                         NO           
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Do you give permission for the research 
supervisors to have access to your anonymous 
responses? 
       YES                         NO 
Do you understand that your participation in this 
study will not result in any risk?       
        YES                        NO 
No pressure was exerted on you to consent to 
participation in this study.    
         YES                       NO 
Do you agree to take part in this interview?          YES                       NO 
I HEREBY VOLUNTARILY CONSENT TO PARTICIPATE IN THE INTERVIEW OF THE 
ABOVE-MENTIONED STUDY: 
 
 
 
Signed/confirmed at…………………………………………..   on  
 
                                                                                                          2017 
 
 Full Name and Signature of Participant 
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Thumb Print of Participant 
 
 
 
 
 
 
 
I hereby confirm that I have explained the 
information given in this document to the 
undersigned participant and was encouraged 
and given ample time to ask questions. 
 
Full name and Signature of Researcher 
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Application to Conduct Research: Clinic/Hospital Manager 
Letter of Invitation to clinic manager 
My name is FADILA JUMARE, and I am a PhD student at the University of Cape Town, South 
Africa. I am conducting research on factors influencing utilization and adherence to Prevention 
of Mother to Child Transmission (PMTCT) of HIV services in Rivers State, Nigeriaunder the 
supervision of Dr Johannes John-Langba. I wish to invite you to consider taking part in this 
study. The study has met the requirements of the Research Ethics Committee of the University of 
Cape Town.  
Aims of the Study 
The study aims to: 
1. Understand the nature of adherence and utilization of PMTCT in Rivers State, Nigeria; 
2. Examine factors that influence decisions to utilize PMTCT services by Women Living with 
HIV/AIDS; 
3. Examine factors that influence adherence to the PMTCT services by women living with 
HIV/AIDS;  
4. Identify the barriers and challenges to adherence and utilization of PMTCT services. 
Significance of the Study 
The study is significant in the following ways: 
 Aid in the integration of PMTCT into sexual and reproductive health programming and 
promote fair distribution of health services in Nigeria. 
 Contribute to improved maternal health, child survival and support for Nigeria’s effort to 
implement the National PMTCT program. 
 Maximize the efficacy of biomedical approaches to HIV prevention. 
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Benefit of the Study to the Clinics 
 Enable health managers to spot concerns of women who are not utilizing or adhering to 
PMTCT services and resolve their needs. 
Research Plan and Method 
Structured questionnaire survey will be administered by the researcher to healthcare staff 
providing PMTCT services in your clinic. Verbal, direct questions will be used to obtain 
participants’ views on how cultural practices and economic statuses affect women’s utilization of 
PMTCT services. Participants will not be required to provide any personal details. To gain access 
to the participants, permission will be sought from the participant prior to their participation in the 
research. The researcher will make appointment with only those who consent. The interview will 
take place in a private room with only the participant and the researcher present and will not be 
more than one hour long. A tape recorder will be used only for the purpose of data analysis. All 
information collected will be treated in strictest confidence and neither the clinic nor individual 
staff will be identifiable in any reports that are written. Participants may withdraw from the study 
at any time without any consequence. The role of the clinic is voluntary and the clinic manager 
may decide to withdraw the clinic’s participation at any time without consequence. The data to be 
collected is merely about participants’ perspectives regarding the issues, data will not be sensitive 
in nature and no harm or risk is faced by any participant or by the clinic. The research is to obtain 
a PhD. It is not for a government program or anything else and therefore data will not be sent 
anywhere and will only be used for completing this degree. 
Clinic Involvement 
Once I have received your consent to approach healthcare staff to participate in the study, I will: 
 Arrange a time with your clinic staff for interview to take place. 
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 Arrange for informed consent to be given to participants and obtain completed informed 
consent forms from participants. 
Attached for your information is a copy of the Participant Information Statement and Consent 
Form. 
Invitation to Participate 
If you would like your clinic to participate in this research, please complete and return the attached 
form. 
Thank you for taking the time to read this information. 
 
FADILA JUMARE       
University of Cape Town, South Africa 
  
176 
 
Clinic/Hospital Manager Consent Form 
I give consent for you to approach clinic staff who are responsible for implementing the PMTCT 
program to participate in the research titled: Factors Influencing Utilization and Adherence to 
Services for Prevention of Mother to Child Transmission of HIV in Rivers State, Nigeria 
I have read the project information statement explaining the purpose of the research project and 
understand that: 
 The role of the clinic is voluntary. 
 I may decide to withdraw the clinic’s participation at any time without consequence. 
 Clinic staff who are responsible for implementing the PMTCT program will be invited to 
participate and that permission will be sought from them.  
 Only clinic staff who consent will participate in the project. 
 All information obtained will be treated in strictest confidence.  
 The purpose of this study is to obtain a degree and not for official government or other use. 
 The staffs' names will not be used and individual staff will not be identifiable in any written 
reports about the study.  
 The clinic will not be identifiable in any written reports about the study.  
 Participants may withdraw from the study at any time without consequence. 
 A report of the findings will be made available to the clinic. 
 I may seek further information on the project from FADILA JUMARE on +2348096387247. 
__________________________   ___________________________ 
Clinic Manager      Signature 
________________________    
Date 
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Application to Conduct Research: NGO Representatives 
Letter of Invitation to NGO Representative 
My name is FADILA JUMARE, and I am a PhD student at the University of Cape Town, South 
Africa. I am conducting research on factors influencing utilization and adherence to Prevention 
of Mother to Child Transmission (PMTCT) of HIV services in Rivers State, Nigeriaunder the 
supervision of Dr Johannes John-Langba. I wish to invite you to consider taking part in this 
study. The study has met the requirements of the Research Ethics Committee of the University of 
Cape Town.  
Aims of the Study 
The study aims to: 
1. Understand the nature of adherence and utilization of PMTCT in Rivers State, Nigeria; 
2. Examine factors that influence decisions to utilize PMTCT services by Women Living with 
HIV/AIDS; 
3. Examine factors that influence adherence to the PMTCT services by women living with 
HIV/AIDS;  
4. Identify the barriers and challenges to adherence and utilization of PMTCT services. 
Significance of the Study 
The study is significant in the following ways: 
 Aid in the integration of PMTCT into sexual and reproductive health programming and 
promote fair distribution of health services in Nigeria. 
 Contribute to improved maternal health, child survival and support for Nigeria’s effort to 
implement the National PMTCT program. 
 Maximize the efficacy of biomedical approaches to HIV prevention. 
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Benefit of the Study to the NGO 
 Enable NGO management to spot concerns of women who are not utilizing or adhering to 
PMTCT services and resolve their needs. 
Research Plan and Method 
Structured questionnaire survey will be administered by the researcher to the NGO staff relating 
with WLWHA in your clinic. Verbal, direct questions will be used to obtain participants’ views 
on how cultural practices and economic statuses affect WLWHAs’ utilization of PMTCT services. 
Participants will not be required to provide any personal details. To gain access to the participants, 
permission will be sought from the participant prior to their participation in the research. The 
researcher will make appointment with only those who consent. The interview will take place in a 
private room with only the participant and the researcher present and will not be more than one 
hour long. A tape recorder will be used only for the purpose of data analysis. All information 
collected will be treated in strictest confidence and neither the clinic nor individual staff will be 
identifiable in any reports that are written. Participants may withdraw from the study at any time 
without any consequence. The role of the clinic is voluntary and the clinic manager may decide to 
withdraw the clinic’s participation at any time without consequence. The data to be collected is 
merely about participants’ perspectives regarding the issues, data will not be sensitive in nature 
and no harm or risk is faced by any participant or by the clinic. The research is to obtain a PhD. It 
is not for a government program or anything else and therefore data will not be sent anywhere and 
will only be used for completing this degree. 
NGO Involvement 
Once I have received your consent to approach NGO staff to participate in the study, I will: 
 Arrange a time with your NGO staff for interview to take place. 
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 Arrange for informed consent to be given to participants and obtain completed informed 
consent forms from participants. 
 
Attached for your information is a copy of the Participant Information Statement and Consent 
Form. 
 
Invitation to Participate 
If you would like your clinic/hospital to participate in this research, please complete and return the 
attached form. 
 
Thank you for taking the time to read this information. 
        
FADILA JUMARE          
University of Cape Town, South Africa  
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NGO Representative Consent Form 
I give consent for you to approach NGO staff who are responsible for implementing the PMTCT 
program to participate in the research titled: Factors Influencing Utilization and Adherence to 
Services for Prevention of Mother to Child Transmission of HIV in Rivers State, Nigeria 
I have read the project information statement explaining the purpose of the research project and 
understand that: 
 The role of the NGO is voluntary. 
 I may decide to withdraw the NGO’s participation at any time without consequence. 
 NGO staff who are responsible for implementing the PMTCT program will be invited to 
participate and that permission will be sought from them.  
 Only NGO staff who consent will participate in the project. 
 All information obtained will be treated in strictest confidence.  
 The purpose of this study is to obtain a degree and not for official government or other use. 
 The staffs' names will not be used and individual staff will not be identifiable in any written 
reports about the study.  
 The NGO will not be identifiable in any written reports about the study.  
 Participants may withdraw from the study at any time without consequence. 
 A report of the findings will be made available to the NGO. 
 I may seek further information on the project from FADILA JUMARE on +2348096387247. 
__________________________   ___________________________ 
NGO Manager     Signature 
_______________________    
Date 
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Appendix 4: Summary of Coding and Responses 
Examples of 
Participants’ Responses 
Concept/Category Variables/ Main 
themes 
 Yes. I attended because 
the life of my unborn 
child was very 
important to me 
 
 Yes. I followed all 
instruction given me 
because I wanted to 
live long. 
 
 Yes. To ensure that the 
baby is HIV negative 
 
 Mothers occasionally 
miss their 
appointments but 
adherence is good 
 
 Yes so as to get the 
medication 
Reasons for PMTCT service use and 
adherence ANC attendance/attitude 
towards follow up visits 
Lives of mother and 
unborn child 
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 Price of the booking is 
a concern 
No I went alone 
Very rare to see partners 
No they usually come 
alone, I have not seen their 
partners. This is still low. 
They go alone mostly. 
Some come with their 
house helps, wasn’t 
married but he didn’t go 
with me 
Male Partner Involvement Lack of support from 
partners 
No only my husband 
No community support 
No I do everything myself 
 
Support received from friends and family Lack of support from 
relatives and friends 
No I did not experience 
any because only me and 
my partner know 
Effects of Stigma and Discrimination Non-disclosure of HIV 
status 
Materials and machines 
are not always available, 
laboratory logistics, cost, 
CD4 count experiences/ Follow up 
counts 
Unavailability of 
service at 
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long list of those waiting, 
delays in getting results, (it 
takes 4 -7 days), and 
hospital related 
difficulties. 
hospitals/quality of 
services provided 
He keeps asking why he is 
the only one taking drugs 
No because I already know 
their status which was 
negative, No because he 
was free from the virus 
Time of baby testing/follow up 
tests/Challenges 
Inaccurate information 
about when to test 
 
Concern that baby will 
know the HIV status 
A few of them already 
know, 1st visit to ANC, 
some know before, some 
at antenatal. I did the test 
four years ago, No I never 
know I was positive, they 
tested me but I knew since 
2011, at 4 months, yes 
after the first child, yes to 
only my partner, yes I 
disclosed to my partner 
Knowledge of HIV status,/Time of first 
test, HIV status disclosure 
Testing late 
Non-disclosure 
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alone, No after my first 
child 
Not up to 18 months,they 
are referred to pediatrics 
and given prophylaxis yes 
four times, some come 
without the baby, mostly 
economic hardships most 
patients are faced with. 
Not anymore/ only at birth 
because he was discovered 
to be HIV negative, No he 
was ok and wasn’t given, 
still low so wasn’t taking, 
Dizziness. 
Immediate postpartum experience of 
WLWHA(Provision of ARV to mother 
and baby, support, challenges, follow up 
visits with baby) 
Failure to attend 
follow up visits with 
baby, side effects of 
ARV medication, 
economic hardship, 
lack of information 
about prophylaxis for 
baby 
They prefer breastfeeding, 
because it’s affordable, yes 
indecision about infant 
feeding before delivery, 
most before 6 months say 
it is stressful at 3 months. 
Yes a few because of 
inadequate information. 
Infant feeding experiences of WLWHA 
(Reasons for choice of infant feeding, 
length of time baby was exclusively 
breast or formula fed, reasons for 
stopping the mode of feeding, constraints 
to chosen infant feeding) 
Confusion about infant 
feeding choices, poor 
lactation, inability to 
cope with EB, working 
mothers, family 
pressures, ignorance, 
poor information about 
baby’s nutrition, 
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They find it strenuous, 
some of them work, 4 
months, 5 months, yes to 
supplement child energy 
demand, money, they 
don’t usually like 
breastfeeding, most of 
them opt for infant formula 
because its cheap, it is less 
likely to be confronted 
about their feeding choices 
if they are breastfeeding, 
some men do not want to 
compromise at all so they 
insist on formula feeding. 
Few, some say I wont give 
at all. I add water to the 
breastfeeding so that he 
would be more satisfied, 
certain persons expressed 
their concerns and 
suggested I switch to other 
food options but I stuck to 
latching problems, 
Acceptance by babies, 
fear of having cuts 
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breastfeeding. I stopped 
breastfeeding at about 8-9 
months. 8 months. After 6 
months I stop. 9 months I 
still breastfed after 6 
months but I introduced 
other fluids. Exclusive 
formula feeding. We were 
informed that 
breastfeeding has a 50% 
chance of infecting the 
child and I didn’t want to 
take the risk. The 
neighbors wanted to know 
why I was not 
breastfeeding. I excused 
myself with a sound 
excuse. Exclusive 
breastfeeding because its 
economical. I couldn’t 
continue due to low milk 
from my breast. I was 
instructed to buy NAN 
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formula. Baby formula. I 
gave milk to the child up to 
2 years of age. Exclusive 
breastfeeding although it 
didn’t come out 
immediately. Exclusive 
breastfeeding. It makes the 
child healthier and cuts my 
expenses on baby food. 
Sometimes people suggest 
that I give him something 
else but I stuck to 
breastfeeding. After three 
weeks the baby was not 
suckling properly so my 
doctor advised me to stick 
with infant formula, I was 
given milk at the hospital 
to give my baby but I also 
gave her breastmilk. They 
told me to breastfeed and 
give food also. I did 
exclusive for 3 months and 
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stopped myself. I had a cut 
in my nipples. 
Second stage of labour, im 
aware that most do not go 
for ANC they attend TBAs 
where they are not 
screened and do not know 
their status. Most women 
prefer vaginal delivery 
regardless of viral load. 
Yes no ANC registration. 
First stage. Unregistered 
cases for ANC 
(Ignorance). Those on 
ARV usually continue 
taking. No majority don’t 
return because of finance. 
Yes. Some do clinic 
elsewhere but want to 
deliver here because of 
safe delivery. We don’t 
have a viral load machine. 
I didn’t know then because 
Labour experiences of WLWHA 
(Time of arrival at hospitalViral load at 
the time of delivery, normal or cesarean 
delivery) 
TBA attendance, Un-
booked cases. 
Reluctance, un-
seriousness, hiding, 
Finance. Too late to go 
to the hospital 
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no such test was 
conducted. There was no 
viral load test in that 
facility at that time. 550 
doctor said I should do CS 
to be on a safer side so they 
booked me. CS. I paid 
myself. My husband paid. 
No. it was late and I could 
not go to the hospital, so a 
hospital staff help me 
deliver at home. 
Yes a few misses are noted 
especially due to TDF side 
effects. Not much support 
I would say. Delay in 
decision making, patients 
in denial, side effects of 
drugs, too many oral 
tablets to swallow or 
swallowing tablets on a 
daily basis, volume of 
clients. Some resist us with 
Challenges of HAART use and 
adherence 
Side effects of drugs, 
administrative 
bottlenecks, shortage 
of drugs supply/stock 
outs, religious factors, 
indirect costs, cultural 
factors 
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various excuses like they 
have been prayed for, 
religious factors can 
hinder the use of 
medication. The HIV 
medication are free but 
they paid for antenatal. 
Sometimes we don’t have 
certain medication. If we 
don’t have, they need to go 
and buy. Previous dosage 
was once every morning 
and evening but now the 
dosage has been changed 
to just every evening and 
the drug seem more potent. 
Feeling dizzy, No I just set 
reminder on my phone. At 
the onset I usually forget 
or feel reluctant. I 
sometimes mix it into my 
meal to enable me take it. 
But after a while, I became 
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consistent and now it feels 
natural to me. I have to eat 
a lot. The pills are very 
large and I have to take 
two. It is free, but the 
transportation to get the 
medication is expensive. 
Continuous temptation 
from recommendation of 
herbal drugs makes it 
difficult to continue with 
the HAART medication. 
Side effects such as 
dizziness and dry lips. It 
sometimes shortens my 
period. Carelessness. Just 
the normal drag from 
suddenly taking drugs 
daily, some dizziness 
even. I did not like it at 
first but now, am used to it. 
I knew my status after 
delivery 
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To properly plan for 
pregnancy in health. Yes 
to regulate family size. 
Yes, to prevent 
transmission of resistant 
strains. Yes, for prevention 
of infection and 
unintended pregnancies. 
so they do not have 
children they cannot take 
care of. Yes, in order to 
pace out pregnancies. No, 
this would be the last. No 
And I don’t want more 
children.To plan and build 
my CD4 count up for the 
next baby. Yes because im 
through with child 
bearing.Modern method 
because I believe it is 
safer. No, the economy is 
not favorable to that. 
Modern, Not sure of 
Use of family planning services (Reasons 
for use of family planning, reasons for 
choice of family planning method) 
Family size, 
unintended 
pregnancies, financial 
reasons, prevent 
transmission, spacing 
pregnancies 
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partner’s faithfulness. No, 
I prefer to be natural “No 
three is ok for me” No it 
fails. No I don’t want. “im 
ok with three”. 
 
 
 
 
